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ABSTRACT 
 
      Sprouting endothelial cells (ECs) use soluble and insoluble cues to guide migration 
and expand the existing vascular network to meet changing trophic needs of the tissue 
during angiogenesis.  A noninvasive and non-destructive nonlinear optical microscopy 
(NLOM) technique was used to optically image endothelial sprouting morphogenesis in 
three dimensional (3D) collagen matrices with simultaneously captured signals from 
collagen fibers and endothelial cells using second harmonic generation (SHG) and two-
photon excited fluorescence (TPF), respectively. Sprout advancement and lumen 
expansion companying with ECM alteration were the synergistic results of membrane-
associated matrix metalloproteinase and cell traction evidenced by proteinase inhibition 
and Rho-associated kinase (p160ROCK) inhibition experiments. These physical EC-
ECM interactions suggest that ECM mechanical properties may influence angiogenic 
responses.  In a 3D angiogenesis model, we measure angiogenic responses as a function 
of collagen matrix stiffness by inducing collagen cross-linking with microbial 
transglutaminase (mTG).  Collagen matrices stiffen with both mTG treatment and 
incubation time as evidenced with biaxial mechanical test results and collagen TPF 
intensity increases with mTG treatment and that the ratio of TPF/SHG correlates with 
biaxial tested mechanical stiffness.  SHG and optical coherence microscopy (OCM) are 
further used to show that other physical properties of the matrix do not change with 
mTG treatment, thus providing the same density but different stiffness with which to 
measure angiogenic responses.  Stiffer matrices promote angiogenesis with more 
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invading sprouts that invade deeper.  No differences in lumen size were observed 
between control and mTG stiffened 3D cultures, but there was evidence of greater 
matrix remodeling in stiffer gels using NLOM.  Results of this study show angiogenic 
responses are enhanced with increasing stiffness and suggest that these properties may 
be used in tissue engineering and regenerative medicine applications to engineer 
angiogenesis. 
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NOMENCLATURE 
 
SMC                           Smooth Muscle Cell 
MMP                          Metalloproteinase 
mTG                           Microbial Transglutaminase 
VEGF                         Vascular Endothelial Growth Factor 
FGF                            Fibroblast Growth Factor 
PDGF                         Platelet Derived Growth Factor 
TGF-β                        Transforming Growth Factor-β  
ADAMs                     a Disintegrin and Metalloproteinase Domains 
ADAMTs                   a Disintegrin and Metalloproteinase with Thrombospondin motifs 
TIMPs                       Tissue Inhibitor of Metalloproteinases            
ECM                          Extracellular Matrix 
EC                              Endothelial Cell 
NLOM                       Nonlinear Optical Microscopy 
SHG                           Second Harmonic Generation 
TPF                            Two Photon Fluorescence 
CIR                            Collagen Intensity Ratio 
CAI                            Collagen Alteration Index 
OCM                         Optical Coherence Microscopy 
 vi 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT ..............................................................................................................  ii 
ACKNOWLEDGEMENTS ......................................................................................  iv 
NOMENCLATURE ..................................................................................................  v 
TABLE OF CONTENTS ..........................................................................................  vi 
LIST OF FIGURES ...................................................................................................  ix 
LIST OF TABLES ....................................................................................................  xii 
CHAPTER I  INTRODUCTION AND LITERATURE REVIEW ......................  1 
Soluble Biochemical Cues for Angiogenesis……. ..............................................  3 
Vascular Endothelial Growth Factor (VEGF)……………..……….. ……….  3 
Fibroblast Growth Factor (FGF)……. .............................................................  4 
Platelet-derived Growth Factor (PDGF)………………………………….….. 4 
Transforming Growth Factor-β (TGF-β)...…………………………………. .        6 
Proteinases Required for Angiogenesis…………………… ................................  6 
Matrix Metalloproteinases (MMPs)…..…. .....................................................  6 
ADAMS and ADAMTS….…. ........................................................................  8 
Serine Proteases ….…. ....................................................................................  8 
Tissue Inhibitors of Metalloproteinases (TIMPs)….…. ..................................  9 
Insoluble Cues-3D Scaffolds….…. ......................................................................  9 
Synthetic and Natural Polymeric Materials ….…. ..........................................  10 
Collagen ….…. ................................................................................................  10 
Influence of 3D ECM Stiffness on Angiogenesis…. ...........................................  24 
Influence of ECM Mechanics on Cell Traction….…. .........................................  26 
 
CHAPTER II  NONLINEAR OPTICAL MICROSCOPY REVEALS  
INVADING ENDTHELIAL CELLS ANISOTROPICALLY ALTER  
THREE-DIMENSIONAL COLLAGEN MATRICES .............................................  29 
 
Overview ……. .....................................................................................................  29 
Introduction…………………………………………………………………… ..      30 
Materials and Methods……………………………………………… .................  32 
Reagents and Chemicals….…. ........................................................................  32 
 vii 
 
Cell and Tissue Culture….…. .........................................................................  33 
EC Capillary Formation in Collagen Gels….…. .............................................  33 
Nonlinear Optical Microscopy….…. ..............................................................  35 
Matrix Metalloproteinase Inhibition Experiments….…. .................................  38 
p160ROCK Inhibition Experiments….…. ......................................................  39 
Tandem GM6001 and p160ROCK Inhibition Experiments….…. ..................  39 
Statistics…..…. .....................................................................................................  40 
Results…..…. .......................................................................................................  43 
Collagen Fibers Dictate the Direction of Sprout Outgrowth ….…. ................  44  
Dissolution of 3D Collagen Fibers Occurs During Invasion ….…. ................  47 
Collagen Matrices Are Reorganized During Cell Migration and Lumen  
Formation ….…. ..............................................................................................  47 
Quantification of Alterations in Collagen Matrix Density at Lumenal  
Branch Points….…. .........................................................................................  50 
Extracellular Matrix Density Increased around Lumens of Invading  
Structures, but not Tips ….…. .........................................................................  52 
Lumen Expansion is Associated with Elevated Collagen Intensity at  
Periphery ….…. ...............................................................................................  56 
Matrix Metalloproteinase Inhibition Increased Collagen Intensity Ratio at  
the Periphery of Lumens while Restricting Advancement of Invading  
Structures ….…. ..............................................................................................  56 
Membrane-Associated Metalloproteinases are Responsible for Regulating 
Collagen Intensity at the Periphery of Lumens… ...........................................  59 
Endothelial Cell Traction Force Contributes to Collagen Matrix Alterations  
at the Periphery of Lumens ….…. ...................................................................  61 
Discussion…. ........................................................................................................  65 
CHAPTER III ANGIOGENIC RESPONSES TO MECHANICALLY AND                                              
MICROSCOPICALLY CHARACTERIZED, MICROBIAL  
TRANSGLUTAMINASE CROSS-LINKED COLLAGEN MATRICES ...............  71 
 
Overview ……. .....................................................................................................  71 
Introduction…...............…………………………………………………………  72 
Materials and Methods……………………………………………… .................  76 
Reagents and Chemicals….…. ........................................................................  76 
Cell Culture….…. ............................................................................................  77 
Collagen Gel for Optical and Mechanical Properties Measurement and  
Angiogenic Evaluation….…. ..........................................................................  77 
Nonlinear Optical Microscopy-Optical Coherence Microscopy  
(NLOM-OCM) Combined System ….…. .......................................................  78 
Biaxial Bioreactor for Mechanical Properties Measurements….…. ...............  81 
Transmitted Light Image Acquisition and Quantification….…. .....................  82 
Statistics…..…. .....................................................................................................  82 
Results…..…. .......................................................................................................  83 
 viii 
 
Nonlinear Mechanical and Optical Properties of mTG Cross-linked  
Collagen Matrices ….…. .................................................................................  83 
Microstructural Properties of Collagen Matrices Remained Unchanged with 
mTG Treatment ….…. ....................................................................................  88 
Matrix Stiffness Promoted Angiogenic Responses….…. ...............................  90 
Lumenogenesis in Stiffer Matrices Resulted in More Collagen Matrix  
Remodeling ….…. ...........................................................................................  91 
Discussion…. ........................................................................................................  97 
CHAPTER IV CONCLUSION AND FUTURE WORK .......................................  106 
Conclusion……. ...................................................................................................  106 
Future Work….…. ................................................................................................  107 
Cell/Matrix Interactions during Angiogenesis in Fibrin and Fibrin/Collagen 
Mixture….…. ..................................................................................................  108 
Influence of Collagen Microstructure on Angiogenesis….…. ........................  111 
Influence of Stiffness Gradient on Angiogenesis….…. ..................................  112 
REFERENCES…. .....................................................................................................  115 
 
 ix 
 
LIST OF FIGURES 
 Page 
      Figure 1-1 ECM morphology of 1 vs. 2.5 mg/ml type I collagen captured  
                           with NLOM ....................................................................................  14 
 
 Figure 1-2 Noninvasive 3D image construction with NLOM ……. ...............  17 
 
      Figure 2-1 Analysis of 3D EC invasion assays using light microscopy and  
                           NLOM ……………….……. .........................................................  45 
 
 Figure 2-2 Invading structures interact with collagen fibers and degrade  
                           collagen ……. ................................................................................  46 
 
 Figure 2-3 Invading ECs alter collagen arrangement and increase collagen  
                           intensity at the periphery of lumens and at bifurcation points …. .  49 
 
      Figure 2-4 Quantification of elevated Collagen Intensity Ratio (CIR)  
                           between bifurcations of invading structures revealed a 4-5 fold                      
                           elevation within fibrous and homogenous collagen matrices  
                           compared with reference collagen intensity……. ..........................  51 
 
      Figure 2-5 Quantification of the CIR at the periphery of invading structures  
                           revealed a significant increase around lumens but not tips… ........  53 
 
      Figure 2-6 Quantification of CIR at the periphery of lumens revealed an  
                           anisotropic distribution of collagen density ……. .........................  54 
 
      Figure 2-7 Time-lapse analyses demonstrate that CIR is proportional to  
                           lumen diameter ……. .....................................................................  55 
 
 Figure 2-8 Addition of a global metalloproteinase inhibitor, GM6001  
                           significantly increased CIR… ........................................................  58 
 
 Figure 2-9 Blocking membrane-associated, but not soluble,  
                           metalloproteinases increases CIR and CAI ……. ..........................  60 
 
      Figure 2-10 p160ROCK inhibition with H1152 decreases CIR and CAI… ......  62 
 
      Figure 2-11 p160ROCK inhibition relaxes CIR and CAI observed with 
                           proteinase inhibition. 3D cultures were established for 24 hours  
                           before invading structures were imaged ……. ...............................  64 
 
 x 
 
      Figure 3-1 Biaxial mechanical tests of acellular cruciform-shaped collagen  
                           gels revealed nonlinear viscous response curves with larger loads  
                           for higher mTG doses and incubation times ……. ........................  84 
 
 Figure 3-2 TPF/SHG ratio correlates with mTG dose and incubation time. ...  85 
 
 Figure 3-3 Load (g) at 5% stretch correlates well with TPF/SHG ratio  
                           compared with SHG mean or TPF mean ……. .............................  87 
 
      Figure 3-4 Representative SHG images of control and mTG-treated  
                           collagen ECM used to create collagen matrix mask which can be   
                           inverted to highlight matrix porosity (negative mask)……. ..........  88 
 
      Figure 3-5 Porosity, pore size and pore number per field of view of collagen  
                           ECM don’t change with mTG treatment ……. ..............................  90 
 
      Figure 3-6 Stiffer matrix promotes angiogenic invasion with more structures  
                           invading deeper into collagen gel ……. .........................................  92 
 
      Figure 3-7 Representative images of simultaneously acquired collagen SHG,  
                           cellular TPF, and non-specific OCM from within control and  
                           mTG-treated 3D cultures ……. ......................................................  93 
 
 Figure 3-8 Greater matrix remodeling is observed during lumenogenesis in  
                           stiffer matrices… ............................................................................  95 
 
 Figure 3-9 Scatter plot of TPF/SHG ratio from 45 images in acellular regular 
                           mTG and denatured mTG-treated collagen gels……. ...................  96 
 
      Figure 3-10 Scatter plots of porosity (A), pore size (B) and pore number (C)  
                           in acellular collagen ECM in control and mTG-treated collagen 
                           gels .................................................................................................  98 
 
      Figure 3-11 Representative SHG and OCM images of acellular control and  
                           mTG-treated collagen gels… .........................................................  99 
 
      Figure 3-12 Cross-sectional images of sectioned cultures stained with  
                           toluidine blue in control and cultures with topically applied mTG 
                           in media above monolayer at 72 hour.……………………………. 103 
 
      Figure 3-13 Number of invading angiogenic invading structure number is  
                          enhanced in mTG-treated collagen ECM but is suppressed in 3D  
                          cultures with topically applied mTG in media above monolayer…  104 
 
 xi 
 
 
      Figure 4-1 Using NLOM-OCM combined system to image acellular fibrin  
                           and fibrin/collagen mixture 3D matrices modulated by thrombin  
                           concentration ……. ........................................................................  110 
 
 Figure 4-2 Mechanical characterizing results by biaxial bioreactor in  
                           collagen with different concentration, different mTG dose 
                           treatment and different incubation time ……. ...............................  113 
 
 xii 
 
LIST OF TABLES 
 Page 
 
      Table 1-1 Human VEGF receptors, ligands and functions ……. ...................  5 
 
 Table 1-2 Comparison between synthetic and natural polymeric materials. ..  5 
 
      Table 1-3 Methods to control topographical properties of type I collagen. ...  12 
 
 Table 1-4 Methods to crosslink type I collagen ……. ....................................  14 
 
      Table 1-5 Comparison between light microscopy and nonlinear microscopy  17 
 
 Table 1-6 Application of NLOM in imaging type I collagen scaffold ……. .  21 
 
      Table 1-7 Application of confocal microscopy in imaging type I collagen 
                           scaffold……. ..................................................................................  23 
 
 Table 1-8 Angiogenesis response to ECM stiffness ……. .............................  25 
 
      Table 2-1 Mean and standard deviation of CIR (Collagen Intensity Ratio)  
                           values at lumens and tips from 7 different invading structures  
                           and their corresponding P values using student’s T-test ……. ......  41 
 
      Table 2-2 Mean and standard deviation of CIR (Collagen Intensity Ratio)  
                           values around lumens from 7 different invading structures and  
                           their corresponding P values using student’s T-test ……. .............  42 
 
      Table 4-1 Groups with same mechanical testing result from gels with  
                           different concentration, mTG dose treatment and incubation …. ..  112 
 
 
 
 
 
 
 1 
 
CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
      Angiogenesis is defined as new blood vessel formation from pre-existing vessels and 
plays a key role in normal tissue growth, wound repair and the progression of malignant 
diseases. Several diseases related to excessive angiogenesis include cancer, 
atherosclerosis, chronic inflammation and diabetic retinopathy, while the diseases related 
to insufficient angiogenesis are myocardial infarction and chronic wound healing [1-4]. 
Regenerative medicine or tissue engineering aims at replacing or regenerating tissue to 
restore, maintain or improve tissue function [5]. Capillaries and the vascular system are 
required to supply nutrients, remove waste products, and control pressure and 
temperature through coordination of vasoconstriction and vasodilation [6-9]. Due to 
diffusion limitations, cells cannot survive more than few hundred micrometers away 
from nearby capillary [10-12]. To create thick tissue is still a major challenge in tissue 
engineering owing to lack of a functional vasculature to provide a nutrient supply [13]. 
In vivo vascularization includes angiogenesis and vasculogenesis, which are different 
processes. In vivo angiogenesis consists of 6 steps: vasodilation, basement membrane 
degradation, adherent cell migration, lumen formation, synthesis of basement membrane, 
and recruitment of pericytes or smooth muscle cells (SMCs) [6, 8, 14-18]. In vivo 
vasculogenesis can be divided into 6 steps as well: differentiation of mesodermal cells 
into angioblasts, endothelial cell (EC) generation from angioblasts, primordial vessel 
formation by ECs that lack lumens, formation of nascent of endothelial tube composed 
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of polarized ECs, primary vascular network formation from an array of nascent 
endothelial tubes, and recruitment of pericytes and SMCs [8, 19]. Therefore, a complete 
understanding of angiogenesis is necessary to prevent disease progression and for proper 
tissue engineering [13]. ECs are the primary cells responsible for initiating angiogenesis 
under the influence of soluble and insoluble biochemical factors. Growth factors and 
lipids deliver potent pro-angiogenic signals that stimulate endothelial outgrowth and 
invasion events which require membrane-associated matrix metalloproteinases (MMPs). 
The extracellular matrix (ECM) is a scaffold that provides mechanical support and 
adhesive contact sites, along with mechanical signals, that combine with biochemical 
cues to promote angiogenesis. In additional to biochemical influences, angiogenesis is 
also affected by mechanical stimuli, such as shear stress and cyclic strain [20-25]. ECM 
stiffness can affect cell behavior but how that affects the interactions between ECs and 
ECM is still not clear. Here, we will brief review various factors that influence 
angiogenesis, such as soluble biochemical cues, proteinases, and insoluble cues (with a 
particular focus on collagen 3D scaffolds). Further, we will discuss how to tune collagen 
topographical properties and mechanical properties and how other groups use nonlinear 
optical microscopy or confocal microscopy to probe optical/topographical/mechanical 
properties of collagen. Finally we will go over other groups’ work on tuning 3D scaffold 
stiffness and its influence on angiogenesis. In chapter II, we elucidated how ECs interact 
with collagen matrices during angiogenesis and lumenogenesis. In chapter III, one 
enzymatic crosslinking method is used, where microbial transglutaminase (mTG) was 
applied to decouple collagen stiffness from its topographical properties and further 
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investigated angiogenic responses and ECs-matrix interactions during lumenogenesis. 
The last chapter includes conclusions from these studies and also possible future 
experiments. The uniqueness of this work is we successfully used mTG to strengthen 
collagen stiffness without changing its microstructure, evidenced with its associated 
mechanical, optical and topographical properties measured with our biaxial bioreactor 
and NLOM-OCM combined system and further proven stiffness of mTG treated 
collagen enhanced angiogenic responses in vitro. Not only capable of characterizing 
optical property and microstructure of ECM noninvasively and nondestructively, NLOM 
also provided spatial and temporal information of EC-matrix and revealed collagen 
alterations during lumenogenesis were associated with lumen size and ECM stiffness 
enhanced EC-matrix interactions around lumens.  The linear relationship between 
TPF/SHG (optical property) and stiffness (mechanical property) shed a light to measure 
ECM with NLOM noninvasively.  
 
Soluble Biochemical Cues for Angiogenesis 
 
Vascular Endothelial Growth Factor (VEGF) 
      The VEGF family contains 5 members, which are secreted and dimeric glycoproteins 
of approximately 40 kDa. The isoforms are VEGF-A (VEGF), -B, -C, -D and placenta 
growth factor (PLGF) [26-31]. The VEGF family of receptors includes three protein-
tyrosine kinases (vascular growth factor receptor-1 (VEGFR-1), VEGFR-2 and VEGFR-
3) and two non-protein kinase co-receptors (neuropilin-1 and neuropilin-2) [29-31]. 
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VEGF binding causes VEGFR activation and the activated VEGFR leads to different 
cellular and angiogenic responses, such as increased EC permeability [32, 33], inhibition 
of EC apoptosis [34], stimulation of EC proliferation [35], enhancement of EC migration 
[36], production of ECM proteases and protease inhibitors from ECs [37], and 
production of nitric oxide synthase [38]. VEGF production is regulated by hypoxia, and 
VEGF isoforms are produced by various cell types, including ECs and tumor cells [27, 
28, 31, 39]. Overall, all human VEGF receptors, their ligands and functions are 
summarized in Table 1-1 [29]. 
Fibroblast Growth Factor (FGF) 
      FGF-1 (acidic FGF) and FGF-2 (basic FGF) both are capable of stimulating 
angiogenesis [40, 41]. The receptor of FGF is FGFR, and there are 4 different types of 
FGFR [42, 43]. The action of FGF is not specific to ECs, and FGFs act on cells derived 
from mesoderm and neuroectoderm, such as ECs, fibroblasts and pericytes [44]. There 
are several EC activities modulated by FGF, which including stimulation of in vivo and 
in vitro angiogenesis [41, 45], stimulation of EC proliferation [46], enhancement of EC 
migration [41, 47] and stimulation of matrix protease production in ECs [48].  
 Platelet-derived Growth Factor (PDGF) 
      PDGF receptors, members of RTK (receptor tyrosine kinase) superfamily, are found 
in ECs, pericytes and SMCs [49-52]. PDGF isoforms are produced by various cells, such 
ECs, fibroblasts, and macrophages [53]. PDGF, the mitogen and chemoattractant for 
most mesenchymal cells [53], stimulates pericyte proliferation [52] and increases 
capillary stability [54-57]. 
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Table 1- 1. Human VEGF receptors, ligands and functions 
receptors ligands functions 
VEGFR1 VEGF-A, VEGF-B, PIGF 
Vasculogenesis, 
angiogenesis, and 
monocyte/macrophage 
motility 
VEGFR2 VEGF-A, VEGF-C, VEGF-D 
Vasculogenesis, 
angiogenesis, vascular 
permeability and endothelial 
cell motility 
VEGFR3 VEGF-C, VEGF-D 
Vascular and lymphatic 
development and 
maintenance 
Neuropilin-1 VEGF-A, VEGF-B, VEGF-C, VEGF-D, PIGF 
Vascular maturation, 
branching and heart 
development 
Neuropilin-2 VEGF-A, VEGF-C, VEGF-D lymphangiogenesis 
 
 
 
 
 
 
Table 1- 2. Comparison between synthetic and natural polymeric materials 
 
 synthetic polymeric material 
natural polymeric 
material 
physical properties 
pure elasticity 
no physical architecture 
small porosity 
non-biodegradable 
viscoelasticity 
physical architecture 
porosity (nm to µm) 
biodegradable 
biochemical properties no natural ligands with natural ligands 
disadvantages stability over time 
difficult to decouple 
mechanics and 
biochemistry 
advantages versatile to control Biomimic 
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 Transforming Growth Factor-β (TGF-β) 
      TGF-β receptors are receptor-type serine/threonine kinases [58, 59]. Both TGF-β and 
its receptors are expressed in full spectrum of vascular cell types, including ECs, smooth 
muscle cells, and pericytes [60]. TGF-β induces angiogenesis via recruiting 
inflammatory cells (monocytes and macrophages) that produce VEGF, FGF-2 and 
PDGF [61-65]. In a co-culture system, TGF-β inhibits EC proliferation upon EC-
pericyte contact [60]. Thus, TGF-β can have both stimulatory and inhibitory effect on 
angiogenesis. 
 
Proteinases Required for Angiogenesis 
 
      ECM is composed of many proteins. Some of these include collagen, elastin, 
fibronectin, laminin and nidogen, as well as proteoglycans and glycoproteins that can be 
degraded by proteases. Proteases have been classified into metalloproteinases, serine 
proteases, and cathepsin cysteine proteases. Metalloproteinases are composed of three 
major families: (1) matrix metalloproteinases (MMPs), (2) a disintegrin and 
metalloproteinase domains (ADAMs), and (3) a disintegrin and metalloproteinase with 
thrombospondin motifs (ADAMTs).  
 Matrix Metalloproteinases (MMPs) 
      There are 23 members of MMP family that share three basic domains, a prodomain 
(at amino terminus), catalytic domain, and hemopexin containing ancillary domains (at 
carboxyl terminus) but some have extra variations. In addition to matrix protein 
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specificity for degradation, MMPs cleave membrane-bound adhesion molecules, matrix-
bound growth factors and other soluble enzymes [66-68]. Therefore, MMPs are divided 
into soluble MMPs and membrane-type MMPs (MT-MMPs).  Soluble MMP include 
collagenases (MMP-1, MMP-8, and MMP-13), gelatinases (MMP-2, MMP-9), 
stromelysins (MMP-3, MMP-10 and MMP-11), matrilysins (MMP-7, MMP-26) and 
metalloelastase (MMP12). The MT-MMPs have 6 members (MMP-14/15/16/17/24/25 
also called MT1/2/3/4/5/6-MMP, respectively), and they are either a type I 
transmembrane domain (MT1/2/3/5-MMP) or a glycosylphosphatidylinositol (GPI) 
anchor (MT4/6-MMP). In collagenases, MMP-1 cleaves type I and type III collagens, 
and MMP-8 and MMP-13 selectively target type I and type II collagens. Three 
principles are required for collagenases to degrade collagen, which include the ability to 
bind collagen molecules, unwind the three α chains, and cleave each strand of the triple 
helix [69, 70]. Regarding gelatinases, MMP-2 and MMP-9 degrades gelatin or denatured 
collagens [71]. MT-MMPs degrade various ECM proteins, such as different types of 
collagen, fibrinectin, gelatin, laminin and fibrin [72]. Five out of six MT-MMPs (not 
MT4-MMP) activate pro MMP-2 [68, 73-76]. ECs produce different MMPs, including 
MMP-1/2/9/13/14. In particular, MMP-2 and MMP-14 (MT1-MMP) have been proven 
in promoting EC migration and capillary network formation [77-80]. After activation by 
a furin-linked enzyme through intracellular cleavage of the pro-peptide domain, MT1-
MMP can cleave ECM or form ternary complexes with tissue inhibitor of matrix 
metalloproteinase-2 (TIMP-2) and pro-MMP-2 (72kDa) to activate pro-MMP-2 into an 
active form (62kDa) [81, 82]. 
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 ADAMS and ADAMTS 
      ADAM and ADAMTS family members have several common structural domains, 
i.e. a pro-domain, disintegrin domain, and metalloproteinase domain. The difference 
between ADAMs and ADAMTSs is that ADAMTSs lack a cysteine-rich domain and 
ADAMTSs are secreted into interstitial space and bind with ECM proteins but not 
ADAMs (membrane-spanning proteins) [83, 84]. 19 out of 34 ADAMs have proteolytic 
activity [83, 85]. ADAMs are also involved in cytokine processing or growth factor 
receptor shedding [86]. Within the ADAMs family, ADAM -10, -15 and -17 are known 
to be involved in angiogenesis [87]. There are 19 members in ADAMTS family and 
ADAMTS-1, -4, -5, -8, -9, -15 and -16 are considered as proteoglycanases [88]. In 
angiogenesis, ADAMTS-1 and ADAMTS-8 have an inhibitory effect and ADAMTS-4 
expressed in ECs promotes formation of capillary tube structures in fibrin matrices [89-
91].  
 Serine Proteases 
      Among serine proteases, urokinase-type plasminogen activator (uPA) and plasmin 
regulate endothelial cell migration [92]. uPA activates plasminogen to generate the 
active protease plasmin to degrade matrix proteins such as fibrin, fibronectin, and 
laminin [93]. This activation process could be accelerated by presence of uPA receptor 
(u-PAR) [94]. Besides uPA, mammalian tissues also express tissue-type plasminogen 
activator (tPA), which activates plasminogen in presence of fibrin [95] and tPA is 
primary expressed by ECs and plays a key role in blood clotting [93]. Both uPA and tPA 
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are inhibited by plasminogen activator inhibitor (PAI).  Plasmin, uPA and PAI-1 all 
participate in angiogenic processes [96, 97]. 
 Tissue Inhibitors of Metalloproteinases (TIMPs) 
      There are 4 different tissue inhibitors of metalloproteinases (TIMPs) which 
specifically block MMP activity. TIMPs are secreted proteins with molecular weights 
from 20 to 29kDa that bind to MMPs in 1:1 ratio to form a complex which will be 
engulfed by macrophages [98]. TIMPs also inhibit proteinases of ADAMs and 
ADAMTSs families [86]. Among all TIMPs, TIMP-1 poorly inhibits membrane-type 
MMPs, such as MT1/2/3/4/5-MMP [99, 100]. Other than mediating pro-MMP2 
activation with MT1-MMP, TIMP-2 inhibits MMPs via an N-terminal region and 
suppresses angiogenesis via a C-terminal region [101]. Among all TIMPs, TIMP-3 is 
unique because it inhibits ADAMs activity, blocks the binding of VEGF to VEGFR-2 
[102], and is bound to sulfated glycosaminoglycans through a heparin binding sequence 
and is not freely diffusible [103]. Compared with TIMP-2, TIMP-4 doesn’t reduce EC 
proliferation but restrict EC motility in vitro, but not in vivo [104], although TIMP-2 and 
TIMP-4 share specificity for inhibiting MMPs and can inhibit not only soluble, but also 
MT-MMPs. 
 
Insoluble Cues-3D Scaffolds 
 
      Cells behave differently in 3D than 2D tissues [105-110], specifically migration 
[107], drug responsiveness [108] and differentiation [109]. There is growing interest in 
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tissue engineering in designing the physical properties of a biomaterial scaffold, 
including topographical and mechanical properties, to influence cell behavior [106, 111-
118]. Topographical properties represent information of ECM architecture in micrometer 
or nanometer scale that cells sense, such as fiber thickness, pore size or porosity [119].  
Synthetic and Natural Polymeric Materials 
      2D/3D polymeric biomaterials used for tissue engineering or mechano-sensitivity 
studies consist of synthetic and natural polymeric materials. Synthetic polymeric 
material includes polyacrylamide (PA) [117, 120-122], polyelectrolyte multilayer film 
(PEM) [123-125], polydimethylsiloxane (PDMS) [126-128] and polyethylene glycol 
(PEG) [129-132]. Natural polymeric materials include collagen [133-135], fibrin [136-
138], hyaluronan (HA) [139-141] and alginate [142-147]. Except PEG [129], very few 
synthetic polymeric biomaterials were used for 3D studies owing to their high density, 
low porosity, and lack of biocompatibility and biodegradability. Compared with other 
polymeric scaffolds, the advantage of using natural polymeric materials is that they 
occur naturally, are synthesized naturally, and are nontoxic. The differences between 
synthetic and natural polymeric materials are summarized in Table 1-2. 
Collagen 
Collagen fibrillogenesis 
      Collagen gels have been applied in various tissue engineering applications, such as 
skin, cartilage, blood vessels and other tissue replacements.  Collagen, the most 
abundant protein in vertebrates, constitutes one quarter of total protein mass of animals. 
Collagen molecule contains a unique triple-helical structure which is constituted by three 
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polypeptide chains (α-chain). The triple helix, known as procollagen, is secreted from 
cells and soluble under physiological conditions.  Tropocollagen is formed after 
removing loose ends of the procollagen by collagen peptidases. Glycine presents at 
every third residue along each chain to allow a tight packaging of three α chains in the 
tropocollagen. Therefore, each of three α chains has the repeating structure Gly-X-Y 
where X, Y could be any amino acid but they are usually proline and hydroxyproline 
[148, 149]. The fibril-forming collagen molecule consists of an uninterrupted triple helix 
that is 300nm in length and 1.5 nm in diameter flanked by an extra telopeptide, which is 
critical for fibril formation. The assembly of collagen from molecules to fibril and into 
fibers occurs through a protein self-assembly and entropy driven process, i.e. collagen 
molecules exclude water and lower surface energy by aggregating [150]. There are 29 
different collagen chains that exist in animals [151]. Collagen types I, II, III, V and XI 
are all characterized with D-periodic cross-striated fibrils (67nm in diameter) [152-155] 
and form fibrous structure. Type I collagen (fibril forming), the major collagen in skin 
and bone, accounts for 90% of total collagen in body. Type II collagen (fibril forming) is 
found in cartilage. Type III collagen (fibril forming) is observed in wound healing and 
developing skin [151]. Type IV collagen (nonfibrillar meshwork) is located in basal 
lamina and basement membranes of blood vessels. Altogether, type I collagen matrices 
will be the major focus of subsequent studies included here. 
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Table 1- 3. Methods to control topographical properties of type I collagen 
 
 collagen concentration topographical characteristics collagen source reference 
collagen concentration 
<5 mg/ml fibril diameter increase with concentration collagen type I [156, 157] 
10-80 mg/ml 
fibril diameter increase 
with concentration 
(20-80nm) 
collagen type I [158, 159] 
90-150 mg/ml 
fibril diameter increase 
with increasing 
concentration  
collagen type I from 
young Wistar rat tail [160, 161] 
200-300 mg/ml 
fibril diameter decrease 
with increasing 
concentration 
collagen type I from 
young Wistar rat tail [160, 161] 
0.5, 1.5, 2.5, 3.5 mg/ml 
fibril density increased 
with increasing collagen 
concentration. 
average fibril diameter did 
not change significantly 
with collagen 
concentration. 
collagen type I [162] 
temperature 
4°C, 22°C, 37°C 
lack of gelation and fiber 
formation at low 
temperature (4, 22°C) but 
not 37°C 
porcine myocardial 
matrix [163] 
22°C, 27°C, 32°C 
matrices with small pore 
size associated with lower 
temperature. 
rat tail tendon (BD) [164] 
25°C, 30°C, 37°C no influence on fibril diameter 
collagen type I  
rat tail tendon [159] 
4°C, 14°C, 24°C, 37°C 
fiber diameter and pore 
size decrease with 
increasing temperature 
collagen type I  
rat tail tendon [165] 
22°C, 37°C 
pore size decrease with 
increasing temperature  
with precise control two-
step fibrillogenesis (lag 
and growth state), 
difference of fiber 
diameter could be 
minimized. 
collagen type I  
Rat tail tendon [164] 
pH 
7.5, 8.5 fiber diameter doesn’t change 
porcine myocardial 
matrix [163] 
from 7.0 to 5.0 fiber diameter decreases from pH 7.0 to  pH 5.0  [159] 
5.5-7.5 
fiber diameter decreases 
(3.7±0.7µm-1.6±0.3 µm) 
Pore size decreases 
(81.7±3.7µm2-7.8±0.4 
µm2) 
rat tail tendon (BD) [166] 
5.0-8.5 fibril diameter decreases collagen type I  rat tail tendon [159] 
5, 7, 9 fibril diameter decreases collagen type I  rat tail tendon [133] 
Ionic strength >24 mM 127-291mM 
low ionic strength limits 
fibril size, at higher ionic 
strength, fibrils are larger 
and aggregated in bundles. 
collagen type I from 
young Wistar rat tail [161] 
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Method to control topographical properties of type I collagen  
      Topographical properties include porosity, pore size and fiber thickness, which is 
what cells sense in their local environment. During collagen self-assembly 
fibrillogenesis, the sigmoidal shape of a rheometric measurement revealed a two phase 
mechanism (nucleation phase and growth phase) [157, 167]. The nucleation step is 
temperature dependent and also able to control the number and diameter of collagen 
fibrils [156, 157, 164, 168]. Topographic properties and gelation kinematics of 
polymerized collagen matrices can be altered via varying temperature, ion concentration, 
phosphate content, pH, and protein concentration during self-assembly [161, 166, 169-
172] (see Table 1-3). Importantly, pore sizes of 10-100 µm allow cells to migrate 
through a scaffold, and pore sizes less than 1 µm allows molecules to diffuse freely. 
Different methods to control topographical properties of type I collagen are summarized 
in Table 1-3. Varying concentration will couple both angiogenesis influencing factor, 
topographical property and stiffness, at the same time (see Figure 1-1). Even collagen I 
and II can form fibrils in vitro, but in vivo, they require fibronectin and integrins as 
organizer to determine the site of fibril assembly and collagen V and XI as the nucleators 
to initiate collagen fibrillogenesis [173]. 
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Figure 1- 1. ECM morphology of 1 vs. 2.5 mg/ml type I collagen captured with NLOM. 
 
 
 
 
Table 1- 4. Methods to crosslink type I collagen 
method  crosslinker observation reference 
physical UV irradiation 
only effective for 
thin/transparent 
scaffold 
[174-176] 
chemical glutaraldehyde potential toxic [163, 177-180] 
chemical carbodiimide potential toxic [181-184] 
enzymatic transglutaminase nontoxic [185-187] 
enzymatic mTG nontoxic [188] 
enzymatic lysyl oxidase nontoxic [189] 
nonenzymatic glycation nontoxic [190-198] 
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Method to control type I collagen mechanical properties 
      Decoupling biochemical, topological and mechanical properties in a 3D environment 
is challenging. Although the stiffness of collagen is strengthened by increasing protein 
density, that will also change other ECM topological properties, such as fiber thickness, 
pore size, and porosity (see Figure 1.1). Instead of varying collagen concentration, the 
stiffness can be modulated via physical, chemical, enzymatical or nonenzymatical 
crosslinkings independent of density [196, 197]. Various methods to crosslink type I 
collagen ECM are summarized in Table 1-4. Among them, tissue transglutaminase (tTG) 
and lysyl oxidase (LOX) are physiologic and all nontoxic for cell. There merits [199, 
200] to use mTG over tTG are (1) Ca2+ independence, (2) higher reaction rate and (3) 
broader substrate specificity. In chapter II, we characterized how mTG modulated 
collagen stiffness without changing topographical properties optically and mechanically 
with our NLOM-OCM combined system and biaxial bioreactor. 
Characterizing mechanical and optical properties of type I collagen scaffolds 
 characterizing mechanical properties of type I collagen scaffolds 
      There are several mechanical tests that can be used to evaluate collagen gel 
mechanics, such as shear rheometry, uniaxial testing, and planar biaxial testing, but each 
has its own merits and limitations. 
      Shear rheometry has been extensively applied in studying collagen fibrillation 
dynamics and bulk viscoelastic properties of collagen gels [165, 166, 201, 202]. Briefly, 
collagen fibrillation begins with a lag phase during nucleation with constant turbidity 
and shear modulus (shear modulus G”> storage modulus G’), followed by a growth 
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phase where turbidity and shear modulus rapidly increases (G’ crossing over G”) until 
finally reaching a plateau where collagen monomers assemble successfully [167]. 
Because this method cannot be performed while maintaining sterility, shear rheometry is 
not suitable for studying collagen matrices remodeled by cells. 
      Uniaxial testing is a simple method that has been exploited in large deformation 
analyses and cell-remodeled collagen gel characterization [203, 204]. The dog bone 
shape with at least 5:1 in aspect ratio is required for homogeneous strain and the shape 
will minimize the stress concentration at grips [203]. Collagen matrices undergoing 
uniaxial tests usually reveals more linear response and less elastic return than native 
collagen tissue due to its less mature and complex collagen fiber microstructure [203]. 
      Planar biaxial testing: compared with uniaxial testing, biaxial testing is more close to 
physiological condition and sufficient to elucidate the anisotropic mechanical properties 
of biological tissues [205-208]. Other than square collagen gel [205, 206], cruciform 
shaped collagen gel [207, 208]  has an advantage of minimizing edge effect and has been 
exploited in biaxial mechanical testing combing with polarized light microscopy [207] 
and NLOM [208]. 
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Table 1- 5. Comparison between light microscopy and nonlinear microscopy 
 
 
 
 
 
 
Figure 1- 2. Noninvasive 3D image construction with NLOM 
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optical characterization of type I collagen scaffolds with Nonlinear Optical 
Microscopy (NLOM) 
      NLOM uses two different types of signals, two photon fluorescence (TPF) and 
second harmonic generation (SHG), to image biological structures with subcellular 
resolution. TPF is used to monitor the dynamic behavior of the chemical components of 
tissue, whereas SHG provides novel ways to investigate their spatial organization. SHG 
doesn’t involve absorption of incident photons; hence, SHG imaging is not compromised 
significantly by photobleaching or phototoxicity. Signals of TPF are emitted 
isotropically but those of SHG are anisotropic. TPF is a nonlinear process since TPF 
depends nonlinearly on the laser intensity, not linearly on fluorescence. Specifically, 
doubling the incident laser intensity produces four times the fluorescence [209]. SHG 
intensity is proportional to the square of the incident light intensity. The reason why we 
adapted NLOM for our study is that compared to traditional light microscopy, there is no 
need to fix tissue or use stain or dye to visualize cell and NLOM also provide 
information of ECM (see Table 1-5). Also, scanning the focus with NLOM generates a 
2D image and by incrementally changing the depth of focus, a stack of images was 
generated and used to reconstruct a 3D view of the tissue (see Figure 1.2). Therefore 
NLOM is a suitable intra-vital microscopy to provide spatial and temporal information 
of cell-matrix interaction during angiogenesis nondestructively and noninvasively. 
      Even confocal microscopy also has ability to create 3D image noninvasively, NLOM 
has multiple advantages over traditional confocal microscopy (one photon fluorescence) 
including [209-213]: 
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1. greater tissue penetration up to the couple hundred micrometer range due to near-
infrared excitation compared with confocal (near 50 µm) and consequently, less scatter . 
2. minimize phototoxicity, photobleaching and photodamaging imposed onto cells and 
tissues due to fluorophores excitation localizing in the focal plane and improve optical 
detection efficiency due to the lack of a detector pinhole, which is necessary for 
confocal. 
3. broader excitation range of multiple fluorophores, compared to single photon 
excitation, allowing multicolor imaging using the same excitation wavelength. 
4. generation of other optical contrast based on nonlinear interactions between light and 
molecules without leading to fluorescence, such as second harmonic generation (SHG). 
Therefore, increase the possibility of combining fluorescence microscopy with other 
detection modes, including higher harmonic generation microscopy and fluorescent 
lifetime imaging.  
 
two photon fluorescence (TPF) 
      TPF involves simultaneously absorption of low energy photons to excite a 
fluorophore, followed by an incoherent emission of fluorescence. There are several types 
of endogenous fluorescence in tissues, such as NADH, keratin, melanin, collagen and 
elastin [212, 214-216]. The major cellular endogenous autofluorescence are from the 
reduced pyridine nucleotides, NADH (reduced form of nicotinamide adenine 
dinucleotide), NADPH (reduced form of nicotinamide adenine dinucleotide phosphate), 
riboflavins and tryptophan [212, 216]. Autofluorescence is also captured from serotonin 
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[217-219], keratin [220], elastin [221-223] and melanin [216, 224, 225]. Fluorescence 
lifetime is specific for fluorophore and its micro environment and does not depend on 
fluorophore concentration [226]. The fluorophore of collagen are fluorescent amino 
acids phenylalanine and tyrosine, the pyridinoline crosslinks and advanced glycated 
endproducts (AGEs) [227]. The pyridolamine crosslink in elastin and collagen is another 
extracellular fluorophore [216]. For collagen I, about 1.7% of all amino acids (55 out of 
3156) are the fluorescent ones, namely phenylalanine and tyrosine [227]. The fluorescent 
amino acid tryptophane is not part of the mature collagen molecule as it contributes only 
to the propeptide that is cleaved during maturation. Collagens I and III differ in their 
amino acid sequence. Collagen I consists of 13 tyrosines, 42 phenylalanines, 107 lysines 
and 1040 glycines in contrast to collagen III which is composed of 18 tyrosines, 27 
phenylalanines, 120 lysines and 1263 glycines per molecules. The emission maxima of 
both collagen I and III are the same around 460nm [228]. Compared with fluorescent 
component of collagen I and III, phenylalanine (2750 ps) has a longer fluorescence 
lifetime than tyrosine (2393 ps). Collagen I is composed of a relative ratio of 76% 
phenylalanine to 24% tyrosine (42-13) in contrast to a collagen III that has 60% 
phenylalanine to 40% tyrosine (27-18). The difference in molecular structure of the 
fluorescent amino acids, phenylalanine and tyrosine, is only addition of hydroxyl group 
to the end of the 6-carbon aromatic ring of phenylalanine. Another fluorescent 
component of collagen is AGE pentosidine and the autofluorescence of collagen in skin  
seems to correlate with the level of pentosidine [227] but placental collagen doesn’t 
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Table 1- 6. Application of NLOM in imaging type I collagen scaffold 
ECM crosslinker Mechanical test observation reference 
collagen I N/A N/A 
1. The trend of collagen 
fluorescence over time is 
dependent on excitation 
wavelength. 
2. Collagen fluorescence spectrum 
is dependent on excitation 
wavelength, polymerize 
temperature and pH. 
[229] 
collagen I glutaraldehyde (GTA) rheology 
1.with polymerization temperature 
decreasing, fiber diameter and pore 
size increase but storage modulus 
and SHG decrease (minimal effect 
on TPF) 
2. fiber diameter accessed from 
SHG is linearly correlated with that 
accessed from SEM but with an 
order of magnitude larger. 
3. crosslinker, GTA increases the 
mean TPF (but not mean SHG) and 
storage modulus. 
[165] 
collagen I N/A rheology 
1. with polymerization pH 
increasing from 5.5 to 8.5, mean 
fiber diameter and pore size 
decrease but storage and shear 
modulus increase. 
2. bulk storage modulus depends 
on pore size and fiber diameter 
which are estimated from SHG. 
[166] 
collagen I glutaraldehyde 
Synergie 100  
(stress-strain 
calibration) 
With TPF and SHG images, 
skewiness and speckle contrast 
from cellularized collagen gels can 
predict E. 
[230] 
collagen I genipin N/A 
1. emission spectrum of genipin 
treated collagen gel is dependent 
on excitation wavelength and also 
incubation time. 
2. fluorescent image revealed that 
genipin induced formation of 
fluorescent strand throughout the 
depth of scaffold. 
[231] 
collagen I glycation N/A 
1. during the course of glycation, 
there is an increase in fluorescence 
and structural alterations within 
scaffold. 
2. with measuring the fluorescence 
intensity at 460 nm max, glycation 
with glyceraldehyde was faster 
compared to ribose and generated 
strong fluorescence signals. 
[232] 
collagen I N/A N/A 
A unified relationship between 
SHG directionality, collagen fibril 
morphology and fibril sizes are not 
likely. 
[233] 
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contain pentosidine. A collagen crosslink, pyridinoline, also generates fluorescence but 
that is not detectable in skin in relevant amounts [234].  
second harmonic generation (SHG) 
      SHG involves conversion of two incident photons with same excitation energy into a 
single photon at twice the excitation energy emitted coherently. The ability to generate 
SHG is peculiar to molecules which are not centrosymmetric. Collage has highly 
crystalline triple-helix structure which is not centrosymmetric; hence it’s very effective 
generator of SHG [235]. SHG is nonlinear process in which two photons of lower energy 
generate a photon of higher energy with twice the frequency (or half the wavelength) of 
incident photon. Besides metal and ion crystals, several biological materials contain 
repetitive or symmetric structural units, including coiled-coil structures and polymeric 
proteins. In addition to fibrillar collagen [235-237], other biological structures also 
produce SHG, such as tubulin [238], myosin [239, 240], cellulose[241], starch [241] and 
DNA [242]. 
 
 
 
 
 
 
 
 23 
 
      Therefore, NLOM is suitable for in vitro, in vivo imaging that requires multicolor 
imaging, deep tissue penetration, low photo toxicity and high resolution. NLOM has 
been exploited in imaging various tissues, such as rat tail tendon [240, 243], skin [221, 
244], and cornea [245, 246]. The intrinsic collagen fluorescence arises from enzymatic 
crosslinks between collagen fibers [247-250], such as pyridinium-type crosslink or from 
nonenzymatic crosslinks, such as glycation. Studies of collagen scaffold optical or 
physcial properties with applying NLOM and confocal microscopy are summarized in 
Table 1-6 and Table 1-7, respectively. Among these comparison tables, we can see that 
both NLOM and confocal microscopy can be used to characterize microstructure but 
NLOM more merits over confocal microscopy, such as characterization intrinsic 
fluorescence of collagen and crosslinker. 
 
Table 1- 7. Application of confocal microscopy in imaging type I collagen scaffold 
ECM crosslinker Mechanical test observation reference 
collagen I N/A rheology 
1. fibril diameter assessed from 
CRM (confocal reflectance 
microscopy) or CFM (confocal 
fluorescence microscopy) 
correlates well with the result from 
SEM. 
2. average structure diameter, 
rather than fibril diameter, is the 
length scale that sets that 
magnitude of the gel elastic 
modulus. 
[201] 
collagen I Hyaluronan (HA) rheology 
Addition of HA subtly altered the 
mechanical properties and structure 
of the composite during gelation 
process and at equilibrium. 
[202] 
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Influence of 3D ECM Stiffness on Angiogenesis 
 
      In 2D angiogenesis, tube formation was decreased with increasing matrix stiffness 
via changing type I collagen concentration [251], matrigel concentration [252], changing 
polyacrylamide (PA) rigidity underneath collagen coating [253] or inducing glycation 
[254]. Compared with 2D models, 3D angiogenesis models more closely mimic 
physiological conditions since cells reside in 3D ECM. In 3D in vitro models, ECs are 
either cultured on top of 3D gels or mixed inside 3D gels for them to migrate into 3D 
ECM to form capillary tubular networks [45, 255-258]. When cultured inside 3D ECM, 
ECs can be resuspended as individual cells [259-261], aggregates [20, 262, 263] or EC-
coated beads [264-266]. In our studies, we used a 3D angiogenesis model that 
incorporates a proangiogenic lipid, sphingosine-1-phosphate (S1P) [267-270], inside 
collagen matrices. ECs were cultured on top of each matrix as monolayer in media 
containing VEGF and bFGF to establish serum-free 3D angiogenesis in vitro model. 
Table 1-8 summarizes various models of 3D angiogenesis used to study alterations in 
matrix stiffness. This list includes multiple studies that use traditional method (vary 
ECM concentration) to vary ECM stiffness which also induce changes of topographical 
and mechanical properties. The studies described here aim to change only matrix 
stiffness (i.e. mechanical property) without changing topographical properties (such as 
pore size, pore number, porosity …etc.). 
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Table 1- 8. Angiogenesis response to ECM stiffness 
 
Cell type ECM type Method to vary stiffness observation reference 
Endothelial colony 
forming  cell (ECFC) 
Collagen type I 
(0.5, 1.5, 2.5, 3.5 
mg/ml) 
Varying concentration 
(0.5-3.5 mg/ml) 
In this in vivo study, total 
vessel density (host+ECFC) 
decreased with increasing 
collagen concentration. 
When counting ECFC vessel 
area only, average or total 
ECFC vessel area were 
increased with increasing 
collagen concentration. 
[162] 
Bovine pulmonary 
microvascular 
endothelial cell 
(BPMEC) 
Collagen I (2.4 mg/ml) Varying pH (5-10) 
Neovessels penetrate deeper 
and have larger lumen in rigid 
gel than in soft gel. 
[133] 
Human umbilical vein 
endothelial cell 
(HUVEC) 
+HUASMC 
Collagen I (2.5 mg/ml) 
Varying 
Glucose-6-phosphate 
(G6P) concentration 
(0, 100, 375mM) 
Compared with control, 
glycated gels resulted in 
shorter vessels with increasing 
branching and higher 
tortuosity. 
[195] 
HUVEC 
Human blood 
outgrowth endothelial 
cell (HBOEC) 
Collagen I (1.5, 3.5 
mg/ml) 
Varying collagen 
concentration (1.5, 3.5 
mg/ml) and gel 
boundary condition 
(float, constrained) 
The balance between cell force 
and matrix stiffness played a 
role in regulating 
angiogenesis. 
Improved capillary 
morphogenesis is formed in 
more malleable environment. 
[271] 
Bovine aortic 
endothelial cell 
(BAEC) 
Polyacrylamide (PA) 
Collagen I (1, 5, 10, 50, 
100 µg/ml) 
Varying PA stiffness 
(200, 1000, 2500, 5000, 
10000pa) and varying 
collagen concentration 
on top of PA (1, 5, 10, 
50, 100 µg/ml) 
1. Cell network assembly 
could occur in compliant 
substrate with sufficient 
surface ligand or in stiffer 
substrate with less surface 
ligand. 
2. Fibronectin polymerization 
stabilized cell-cell contacts 
and is necessary for network 
formation regardless of 
substrate stiffness or density of 
surface ligand. 
[272] 
EC fibrin 
Varying fibrin 
concentration (1, 1.5, 
2.0, 2.5, 5, 10 mg/ml) 
In 3D fibrin gel, the biphasic 
trend has been revealed in 
angiogenic sprouting and rate 
of ECM displacement and 
optimal rate will occurred at 
2.5 mg/ml. 
[136] 
HUVEC fibrin 
Varying fibrin 
concentration (2.5, 5, 
10 mg/ml) 
Total capillary network length 
decreased with increasing 
fibrin density. 
[137] 
HUVEC fibrin 
Varying fibrin 
concentration (1, 2, 3 
mg/ml) 
1. For the intermediate fibrin 
concentration (2 mg/ml), the 
angiogenic sprouting proceeds 
faster (biphasic trend). 
2. Rigidity is more important 
than adhesion ligand number. 
2D [138] 
HUVEC fibrin 
Varying fibrin 
concentration (2.5, 5, 
10 mg/ml) 
Increasing the matrix density 
could reduce neovessel 
network formation and that 
effect could be abrogated by 
distributing fibroblast 
throughout the matrix. 
[273] 
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Influence of ECM Mechanics on Cell Traction 
 
      ECs reside within the inner layer of blood vessels above the basal lamina as a 
monolayer [274] and control vascular tone, vascular permeability, and prevent 
coagulation [275]. Capillaries are surrounded by pericytes, specialized mural cells, to 
confer stability and quiescence to capillaries [60, 276]. Larger vessels contain a layer of 
smooth muscle cells (SMC) within the media and connective tissue within the adventitia 
[277]. ECs are subjected to various mechanical stimuli on the apical cell membrane, 
which are transmitted through cell-cell contacts and ECM adventitial layers [275]. Those 
mechanical stimuli include shear and pressure stresses acting on the EC apical 
membrane, residual hoop stress in the vascular wall, external forces from surrounding 
tissues that impinge vessels [278], and mechanical input from surrounding ECM 
stiffness. In response to various mechanical stimuli, ECs are able to exert force against 
their ECM to remodel ECM [279], assist in cell adhesion and migration [280, 281] and 
influence cellular mechanotransduction [275, 282]. The ECM mechanics and 
mechanotransduction have been associated with various pathologies, such as 
cardiovascular diseases (hypertrophy, hypertension and atherosclerosis) [105, 275], 
tumorigenesis [283], metastasis and wound healing [284]. EC traction generation is 
enabled by stress fibers or bundles of actin filaments, myosins and integrins that anchor 
the cells to its substrate through focal adhesion (FA) [285]. FAs are large structurally 
polarized adhesion sites with their proximal ends linking with contractile actin bundles, 
i.e. stress fibers and their formation is associated with natural matrix proteins or 
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arginine-glycine-aspartate (RGD) motifs [286, 287]. Besides integrins, FAs are formed 
with other FA adapter proteins, including vinculin, paxillin, talin, α-actinin, zyxin [288-
290], VASP [291], focal adhesion kinase (FAK) [292-294] and p130Cas [295, 296]. 
Contractile ability within the cell influences the growth and maintenance of FAs. For 
example, inhibition of myosin II activity induces disappearance of FAs [297-299] and 
activation of myosin II induces FA assembly [300-302]. Actin polymerization and FA 
formation are different in 3D versus 2D environments [110]. The Rho-family of 
GTPases includes RhoA, RhoB, RhoC, Rac1 and Cdc42. These small GTPases control 
integrin-mediating signaling [303-305], cell migration [306-308], and intracellular 
contractility and tension [309, 310]. Greater myosin light chain phosphorylation [311] 
mediated via activation of RhoA [312, 313] causes increase contractility. Rho-associated 
protein kinase (ROCK), downstream effector of RhoA, plays a role in actin contractility 
via regulating the phosphorylation of myosin light chain and hence the interaction 
between actin and myosin II [314]. The amount of traction generated by cells is 
dependent on ECM stiffness [113, 315, 316] where cell traction force increases with 
substrate stiffness [113]. Therefore, stiff ECM promotes cell spreading, large FAs, large 
stress fibers and strong traction forces [317, 318]. Califano et al. further confirmed that 
substrate stiffness and cell area could predict cell traction in single cells or even cells in 
contact [319]. Similar to FA, cadherin mediated cell-cell adherens junctions (AJ) also 
depends on myosin II driven contractility [320] and size of cell-cell AJs is regulated by 
mechanical tugging forces [321]. Modulation of ECM properties not only impacts cell-
ECM traction but also alters cell-cell tension [322]. Liu et al. further proposed that cell-
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cell tugging force is important in mediating AJs via myosin activation or inhibition 
[321]. Therefore, the dynamic coordination of traction at cell-ECM interface is critical to 
the maintenance of vascular integrity and ultimate control of vascular permeability. 
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CHAPTER II 
NONLINEAR OPTICAL MICROSCOPY REVEALS INVADING ENDTHELIAL 
CELLS ANISOTROPICALLY ALTER THREE-DIMENSIONAL COLLAGEN 
MATRICES 
 
Overview 
 
      The interactions between endothelial cells (ECs) and the extracellular matrix (ECM) 
are fundamental in mediating various steps of angiogenesis, including cell adhesion, 
migration and sprout formation. Here, we used a noninvasive and non-destructive 
nonlinear optical microscopy (NLOM) technique to optically image endothelial 
sprouting morphogenesis in three dimensional (3D) collagen matrices. We 
simultaneously captured signals from collagen fibers and endothelial cells using second 
harmonic generation (SHG) and two-photon excited fluorescence (TPF), respectively. 
Dynamic 3D imaging revealed EC interactions with collagen fibers along with 
quantifiable alterations in collagen matrix density elicited by EC movement through and 
morphogenesis within the matrix. Specifically, we observed increased collagen density 
in the area between bifurcation points of sprouting structures and anisotropic increases in 
collagen density around the perimeter of lumenal structures, but not advancing sprout 
                                                            
 The content of chapter II is reprinted with permission from “Nonlinear Optical Microscopy Reveals 
Invading Endothelial Cells Anisotropically Alter Three-Dimensional Collagen Matrices” by Po-Feng Lee, 
Alvin T Yeh and Kayla J Bayless, 2009. Experimental Cell Research, Volume 35, P396-410, Copyright 
[2012] by ELSEVIER. 
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tips. Proteinase inhibition studies revealed membrane-associated matrix 
metalloproteinase were utilized for sprout advancement and lumen expansion. Rho-
associated kinase (p160ROCK) inhibition demonstrated that the generation of cell 
tension increased collagen matrix alterations. This study followed sprouting ECs within 
a 3D matrix and revealed that the advancing structures recognize and significantly alter 
their extracellular environment at the periphery of lumens as they progress.  
 
Introduction 
 
      Angiogenesis, the process of new blood vessel growth from existing structures, plays 
a key role in normal tissue growth, wound repair and the progression of malignant 
diseases [323, 324]. Cell migration, proliferation, intracellular alignment, adhesion, and 
lumen formation coordinate to allow ECs of existing vessels to detach from the vascular 
wall, degrade and penetrate the underlying basal lamina while invading the surrounding 
3D interstitial ECM during angiogenesis [325-327]. The ECM is a scaffold that provides 
structural support and adhesive contact sites, along with mechanical signals, that 
combine with biochemical cues to promote angiogenesis.   
      Cell movement through 3D matrices is a precisely coordinated process. Growth  
factors and lipids, such as sphingosine-1-phosphate (S1P), deliver potent pro-angiogenic 
signals [270, 328, 329] that stimulate endothelial outgrowth and invasion events and 
require membrane-associated (but not soluble) matrix metalloproteinases (MMPs) [330].  
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In particular, these events require MT1-MMP [80, 331-333], which selectively degrades 
ECM proteins at the cell surface-ECM interface without affecting the integrity of the 
ECM scaffold. Thus, newly-sprouting ECs integrate signals from pro-angiogenic stimuli 
to initiate successful proteinase-dependent outgrowth in 3D matrices.  
      Here, we utilize an in vitro model [330] that mimics the sprouting step of 
angiogenesis where ECs are allowed to invade in 3D collagen matrices. Collagen is the 
most abundant ECM protein in the body and strongly promotes EC morphogenesis 
[327]. Collagen is a hierarchal structured protein with long range molecular order and 
appreciable nonlinear susceptibility for SHG [243, 334-339]. SHG in collagen can be 
utilized in NLOM for serial imaging of live tissue and defining ECM morphology 
without using exogenous stains or dyes [337]. SHG has been utilized to image collagen 
dynamics and structures of intact and explanted tumors [340-343], mammary glands 
[340, 344], cardiovascular structures [345, 346], skin [222, 342, 347], fibrotic lung tissue 
[348] and cornea [349]. The utility of NLOM for collagen imaging can be further 
enhanced using TPF.  TPF can arise from the nonlinear excitation of cell endogenous 
molecular fluorescence [350] and TPF signal can be used in NLOM to observe cell 
morphology in detail [346]. In addition, TPF signal can be greatly enhanced by cellular 
expression of endogenous fluorophores, such as enhanced green fluorescent protein 
(EGFP). Although much work has been done to define the cellular signals required by 
ECs to undergo morphogenesis and mediate angiogenic events, less is known about the 
molecular and structural interactions that occur between ECs undergoing morphogenesis 
and the surrounding 3D ECM.  
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      Cell migration in two dimensions requires the generation of tension. The small 
GTPase Rho promotes stress-fiber assembly and focal adhesions formation through Rho-
associated kinase (p160ROCK) activation, which also increases contractility [314, 351-
354].  In addition, p160ROCK signaling provides not only a framework to maintain cell 
shape, but also the driving force to alter cell morphology [355, 356] and promote 
directed cell migration [307, 357, 358]. In this study, we use metalloproteinase and 
p160ROCK inhibitors to demonstrate that proteolytic activity at the cell surface is 
coordinated with the generation of tensional forces at the periphery of lumens, where 
anisotropic forces are applied to the underlying collagen matrix. We utilize NLOM to 
quantify alterations in collagen matrices elicited by ECs with time. 
 
Materials and Methods 
 
Reagents and Chemicals      
Rat-tail Collagen type I was obtained from BD Biosciences. Recombinant human 
vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) were 
purchased from Upstate Biotechnology. Medium 199 (M199) and fetal bovine serum 
(FBS) were from Invitrogen. Tumor promoting antigen (TPA, Phorbol 12-myristate 13-
acetate) and ascorbic acid (AA) were purchased from Sigma (St. Louis, MO). 
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Sphingosine-1-phosphate (S1P) was purchased from Avanti Polar Lipids (Alabaster, 
AL). 
Cell and Tissue Culture 
Primary human umbilical vein endothelial cells (ECs) were purchased from Cambrex 
and used at passage 2-6. ECs were grown on gelatin-coated tissue culture flasks (1 
mg/ml) in culture media that consisted of M199 containing 15% fetal bovine serum, 400 
µg/ml bovine hypothalamic extract [359], 100 µg/ml heparin (Sigma), 0.1% gentamycin 
and 1% penicillin/streptomycin (Invitrogen). Cells were passaged once a week. Stable 
EC lines expressing EGFP were generated using a recombinant lentivirus system 
(Invitrogen). pLenti6/V5 clone expressing EGFP [333] was a generous gift of Dr. 
George Davis (University of Missouri, Columbia). Backbone plasmid (4.5 µg) along 
with Virapower plasmid (13.5 µg) was transfected into 293 FT packaging cell line 
(Invitrogen) in 75 cm2 tissue culture flasks using 36 µl Lipofectamine 2000. 
Supernatants were collected at 72 hours, centrifuged at 350Xg for 3 minutes, filtered and 
used fresh to transfect passage 2 ECs. Following blasticidin selection (5 µg/ml) for 2 
weeks, cells were frozen down at passage 3 or used in experiments. 
EC Capillary Formation in Collagen Gels 
3D angiogenesis invasion assays were generated in a two-step process. The collagen 
matrix was prepared prior to seeding an endothelial monolayer on the collagen surface. 
Fibrous collagen gels (3.6 mg/ml) were assembled with rat-tail type I collagen, 
5xDMEM, reconstitution buffer and neutralized with 1M NaOH [339] before 
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incorporating 1 µM S1P, which enhances EC invasion [330]. To ensure matrix 
alterations were not due to nonhomogenous distribution of fibrous collagen, it was 
necessary to create homogeneous collagen matrices in which no fibers could be resolved 
by NLOM.  To accomplish this, 300 mg of rat-tail type I collagen (BD Biosciences) was 
frozen and thawed prior to being lyophilized and resuspended at 7.1 mg/ml in 0.1% 
acetic acid. We determined empirically this result in formation of homogenous collagen 
fibers (data not shown). For all collagen matrices, after thorough mixing of components, 
1ml of collagen mixture was added per well of a Falcon 12-well plate (Becton 
Dickinson). Gels were allowed to polymerize and equilibrate for 20 minutes at 37°C in a 
CO2 incubator prior to seeding 3.6x105 cells per well in serum-free Medium 199 
containing reduced serum supplement II (RSII) [360], recombinant VEGF (40 ng/ml), 
recombinant FGF-2 (40 ng/ml), ascorbic acid (50 µg/ml) and TPA (50 ng/ml). After 
allowing ECs to attach to the collagen matrix for 20 minutes, an additional 3 ml of 
identical serum-free media was added to each well. Cultures were imaged live or 
allowed to proceed for the times indicated before fixing in 4% paraformaldehyde in PBS 
prior to imaging. 
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Nonlinear Optical Microscopy       
System setup     
      Our custom-built NLOM system has been described previously [361].  Briefly, sub-
10-fs pulses from a Ti:Al2O3 oscillator (Femtosource, Femtolasers) pumped by a 
Nd:YVO4 solid state laser (Verdi, Coherent) are coupled into the epi-fluorescence port 
of an upright microscope (Axioskop2 MAT, Carl Zeiss GmBH) via dual-axis 
galvanometer driven mirrors (Model 6220, Cambridge Technology) mounted on an 
elevated breadboard.  The beam is directed to the microscope objective by a short pass 
dichroic mirror (635dcspxruv3p, Chroma).  Nonlinear optical signals are collected by the 
40X focusing objective (NA=0.8) and directed to a custom built two channel detector 
unit mounted on one of the dual accessory ports of the binocular head.  The detector unit 
houses two dichroic mirrors and bandpass filters (Chroma), focusing lenses (PCX, focal 
length: 50 mm, 312321, Linos Photonics), and a pair of photon-counting photomultiplier 
tubes (R7400P, Hamamatsu). Appropriate long pass dichroic mirrors and bandpass 
filters are used for SHG (430dcxru and HQ405/40, respectively; Chroma) and TPF 
detection (580dcxr and HQ480/40, respectively; Chroma).  In imaging mode each 
photomultiplier tube is connected to a preamplifier/discriminator (F-100T, Advanced 
Research Technologies) that thresholds signal current and converts to TTL pulses for 
photon counting.  Image intensities are displayed in photon counts per second on a PC 
(Optiplex GX280, Dell).  Our laser spectrum is 133 nm FWHM centered at 800 nm. 
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Throughout this experiment, less than 40 mW of laser power was incident on the 
scanning mirror that is approximately10 mW at the sample.       
Image processing       
    For morphogenesis studies, live EC invasion was imaged without stains using NLOM 
rendering en face, 2D intensity images. By incrementally changing the depth of focus, a 
stack of images was generated and used to reconstruct 3D visualization of the tissue. 
SHG and TPF signals were collected simultaneously with NLOM. Image files captured 
using NLOM were converted from 16-bit to 8-bit files via MATLAB by scaling the 
maximum pixel value to 255 and then processed in the MetaVue software to generate 3-
D image.  
Collagen density quantification    
      Collagen density was quantified from individual optical sections using Matlab 
software.  Collagen intensity ratio (CIR) was calculated by normalizing SHG intensity at 
the region of interest against the surrounding reference intensity within the NLOM 
image. Reference intensity was obtained by dividing the SHG intensity by the overall 
pixel number outside the area of interest. To quantify collagen density around the 
perimeter of invading EC structures, optical sections of lumen and tip were selected and 
the cell profile within the image was delineated by TPF.  A vertical (V) line was chosen 
to divide the cell profile along its longest axis symmetrically.  The corresponding 
horizontal (H) line intersected the vertical line perpendicularly at the point of maximum 
cell width.  These designations allowed the cell boundary and lumen dimensions to be 
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obtained. The lumen dimensions are defined as the mean value of lumen size along H 
and V axes. CIR values were calculated at the four regions intersecting the vertical and 
horizontal lines at cell periphery (designated LumenV1, LumenV2, LumenH1, LumenH2).  
Data values represent the average of the 5 maximum CIR values obtained from 10 
pixels, which translates to approximately 7 microns beyond the cell boundary.  
Invasion distance measurement  
      To quantify invasion distance, photographs of invading cells were taken from a side 
view with an Olympus CKX41 microscope equipped with a Q color 3 Olympus camera. 
Invasion distance measurement (n=50 cells) were measured digitally using QCapture 
software (Olympus/Leeds) and pixel values were converted to microns. 
Transmitted light image acquisition 
      Toluidine blue staining was conducted on cultures fixed in 3% glutaraldehyde in 
PBS as previously described [9]. In live cultures, experiments were established for 24 
hours in a tissue culture incubator (37°C, 5% CO2, 85% humidity) using a slide assay 
previously described [362] prior to imaging. Slides were placed in an environmental 
chamber on a Nikon TE2000 imaging system. DIC images (10 micro sec exposure) were 
collected at 20x every 6 minutes for 24 hours. Selected images are shown. 
NLOM time-lapse image acquisition 
      Cultures were established and incubated (37°C, 5% CO2) for the times indicated in 
each experiment. For initial image analysis, culture media was removed and replaced 
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with sterile PBS and transported to the NLOM system, which was hooded with 5% CO2 
custom environmental chamber for imaging. Each structure required approximately 20-
30 minutes. Following completion, PBS was removed and media replaced before 
returning to the humidified tissue culture incubator. The imaging position was recorded 
using the position readout of the motorized stage to capture the same field at the next 
time point. 
Matrix Metalloproteinase Inhibition Experiments 
      To investigate whether matrix metalloproteinases (MMPs) are involved in generating 
collagen alterations, GM6001 (a universal MMP inhibitor) was used initially.  To 
determine whether soluble or membrane-associated MMPs were involved in generating 
collagen alterations, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-3 were 
applied.  GM6001 (Calbiochem) was reconstituted in DMSO at 2.57 mM, aliquoted and 
stored at -80°C prior to use at a final dose of 2.5 µM. Cultures were established for 24 
hours and imaged live with NLOM before adding DMSO or GM6001 to the media. 
Cultures of DMSO and GM6001 were allowed to proceed for additional 24 hours and 
then imaged again at 48 hours.  
      Recombinant TIMP-1 and TIMP-3 were isolated from 293 cells transfected with 
adenovirus delivering TIMP-1 and TIMP-3 fused to a C-terminal His tag (constructs will 
be described elsewhere). Confluent monolayers of 293 cells were seeded in duplicate 75 
cm2 flasks. Each flask was infected with 6104  IFU/cm2 and allowed to express for 48-
72 hours. Successful transduction was monitored by expression of green fluorescence 
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protein. Prior to collecting M199 containing conditioned media, the cells were rinsed 
twice with M199 (15 ml). Heparin (100 µg/ml) was added and incubated for 14 hours. 
Conditioned media were purified using 0.5 ml Nickel affinity resin (Novagen) by 
incubating overnight with gentle shaking at 4°C. Proteins were eluted with 0.2 M 
Imidazole and dialyzed overnight against M199. 
p160ROCK Inhibition Experiments 
      The p160ROCK inhibitor, H1152 (Calbiochem) was reconstituted in sterile 
deionized water at 12.7 mM, aliquoted and stored -80°C prior to use. Cultures were 
established for 48 hours and imaged live with NLOM before adding ddH2O or H1152 
(30 µM) to the media. Cultures were allowed to proceed for additional 24 hours and then 
imaged again at 72 hours.  
Tandem GM6001 and p160ROCK Inhibition Experiments 
      Invasion cultures were established for 24 hours and imaged with NLOM prior to the 
addition of the global MMP inhibitor, GM6001 (2.5 µM). Cultures were allowed to 
develop from 24-48 hours. After imaging at 48 hours, the cultures were treated with 
vehicle or H1152 (30 µM) and imaged for the final time at 72 hours. 
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Statistics 
 
      Relative collagen intensities were compared at the lumen and tip sites from seven 
individual invading structures in a homogeneous collagen ECM. In GM6001 and 
p160ROCK inhibition experiments, comparisons are made between the number of 
invading structures indicated in each treatment group. The mean and standard deviation 
were calculated for four regions defined by horizontal and vertical axes at the lumen and 
tip and grouped in Table 2-1. In addition, mean relative collagen intensity values and 
their standard deviations were calculated for the four regions of EC structures with 
lumens, compared using Student’s T-test and tabulated in Table 2-2. P-value < 0.05 was 
considered a significant difference.  
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Table 2- 9. Mean and standard deviation of CIR (Collagen Intensity Ratio) values at 
lumens and tips from 7 different invading structures and their corresponding P values 
using student’s T-test  
 
Sample#  mean std LumenH LumenV TipH TipV 
1 LumenH 4.7038 0.49981   P<0.0005P<0.0005
 LumenV 4.0825 0.50165   P<0.0005 P<0.001
 TipH 1.2348 0.20867 P<0.0005P<0.0005   
 TipV 1.5695 0.22619 P<0.0005 P<0.001   
2 LumenH 3.5466 0.51256  P<0.01 P<0.005 P<0.0005
 LumenV 5.1002 0.49148 P<0.01  P<0.0005P<0.0005
 TipH 1.2494 0.45337 P<0.005 P<0.0005   
 TipV 0.62469 0.22669 P<0.0005P<0.0005   
3 LumenH 4.9575 0.52438   P<0.0005P<0.0005
 LumenV 5.4533 0.6665   P<0.0005P<0.0005
 TipH 1.2494 0.45337 P<0.0005P<0.0005   
 TipV 0.62469 0.22669 P<0.0005P<0.0005   
4 LumenH 3.5469 0.18145  P<0.0005P<0.0005P<0.0005
 LumenV 2.3009 0.071465P<0.0005  P<0.01 P<0.005
 TipH 1.6808 0.23753 P<0.0005 P<0.01   
 TipV 1.28 0.35819 P<0.0005P<0.0005   
5 LumenH 3.0225 0.2374   P<0.001 P<0.01 
 LumenV 3.1256 0.2055 P<0.001  P<0.0005 P<0.005
 TipH 1.9043 0.1173 P<0.01 P<0.0005   
 TipV 1.926 0.395 P<0.0005 P<0.005   
6 LumenH 2.7064 0.2059  P<0.0005P<0.0005P<0.0005
 LumenV 1.2952 0.1887 P<0.0005  P<0.01 P<0.005
 TipH 0.849 0.1279 P<0.0005 P<0.01   
 TipV 0.7525 0.0876 P<0.0005 P<0.005   
7 LumenH 2.4417 0.13026  P<0.05 P<0.001 P<0.005
 LumenV 2.113 0.16471 P<0.05  P<0.005 P<0.01 
 TipH 1.2659 0.26899 P<0.001 P<0.005   
 TipV 1.3299 0.27276 P<0.005 P<0.01   
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Table 2- 2. Mean and standard deviation of CIR (Collagen Intensity Ratio) values 
around lumens from 7 different invading structures and their corresponding P values 
using student’s T-test  
 
Sample#  mean std LumenH1 LumenH2 LumenV1 LumenV2
1 LumenH1 4.552 0.90104    P<0.025
 LumenH2 4.85550.85843    P<0.01 
 LumenV1 5.00310.80636    P<0.01 
 LumenV2 3.16180.39505 P<0.025 P<0.01 P<0.01  
2 LumenH1 3.34240.82926   P<0.0005 P<0.025
 LumenH2 3.75090.36775   P<0.0005 P<0.005
 LumenV1 8.17020.62358P<0.0005P<0.0005  P<0.0005
 LumenV2 2.03020.43854 P<0.025 P<0.0005P<0.0005  
3 LumenH1 5.89390.38213  P<0.01 P<0.005 P<0.025
 LumenH2 4.02110.93601 P<0.01  P<0.005 P<0.005
 LumenV1 9.7498 1.3187 P<0.005 P<0.005  P<0.0005
 LumenV2 1.15680.33165 P<0.025 P<0.005 P<0.0005  
4 LumenH1 4.07440.33423  P<0.01 P<0.005 P<0.0005
 LumenH2 3.01950.42574 P<0.01   P<0.005
 LumenV1 2.95360.32766 P<0.005   P<0.005
 LumenV2 1.64820.34886P<0.0005 P<0.005 P<0.005  
5 LumenH1 2.4864 0.3037  P<0.01 P<0.005  
 LumenH2 3.5587 0.4811 P<0.01   P<0.025
 LumenV1 3.706 0.2563 P<0.005   P<0.005
 LumenV2 2.5453 0.39  P<0.025 P<0.005  
6 LumenH1 2.4139 0.2526  P<0.05 P<0.005 P<0.0005
 LumenH2 2.9988 0.4053 P<0.05  P<0.005 P<0.0005
 LumenV1 1.2936 0.3002 P<0.005 P<0.005   
 LumenV2 1.2967 0.1134 P<0.0005P<0.0005   
7 LumenH1 1.8548 0.2048  P<0.005 P<0.005 P<0.01 
 LumenH2 3.02870.35907 P<0.005   P<0.0005
 LumenV1 2.99350.25075 P<0.005   P<0.0005
 LumenV2 1.23260.23108 P<0.01 P<0.0005P<0.0005  
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Results 
 
      NLOM captures signals from cells via TPF as well as individual collagen fibers by 
SHG, allowing simultaneous visualization of both constituents to better understand the 
interactions between them during angiogenic events. Here, we utilized a 3D model of EC 
invasion that mimics angiogenesis [330]. In this model, ECs stably EGFP were seeded 
on the upper surface of 3D collagen matrices and stimulated to invade using the pro-
angiogenic molecules S1P, VEGF and bFGF. In these experiments, ECs migrated from 
the monolayer into the underlying collagen matrix (Figure 2-1). Figure 2-1A illustrates 
that capillary structures assemble to form multicellular structures containing lumens.  A 
lumen forming an angiogenic sprout was captured extending from the surface monolayer 
(white arrowheads) with matrix interrogating cell processes (gray arrow) from the tip 
(Figure 2-1A).  These invading structures are typically multicellular, as indicated by 
multiple stained nuclei (gray arrowheads). Further, photographs of live ECs migrating 
through 3D collagen matrices (Figure 2-1B) revealed that the invading structures appear 
to alter the collagen matrix as they migrate. Visible alterations were observed in the 
matrix following the migration of an invading endothelial structure (indicated by black 
arrowheads), which is consistent with previous work [330]. Although these studies with 
transmitted light were useful for revealing details about the morphology and architecture 
of invading cellular structures, subsequent studies with NLOM revealed clear orientation 
of collagen fibers along with EC architecture. In Figure 2-1C, TPF images were 
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collected, digitized and stacked to provide a 3D reconstruction of live invading ECs after 
18 hours in culture.  Angiogenic sprouts were observed to both extend from the surface 
monolayer (white arrowheads) and migrate into the matrix (gray arrows).  Overlay of 
TPF signal (green) with SHG (red) allowed visualization of EC angiogenic structures, 
3D organization of collagen fibers and their interspatial relationships (Figure 2-1D).  
NLOM resolved extended peripheral tip processes (gray arrow), small vacuoles (black 
arrow), and lumens formed inside invading structures (black arrowhead) (see Figure 2-
1E). Thus, NLOM is useful to more closely define the nature of collagen matrix 
alterations induced by invading EC structures with high fidelity. 
Collagen Fibers Dictate the Direction of Sprout Outgrowth 
      To investigate more closely the signals that dictate sprout extension and retraction, 
we utilized NLOM to observe interactions between the collagen matrix and invading 
cells (Figure 2-2). Analysis of individual sections of SHG and TPF data revealed that 
extended peripheral sprout processes extended along collagen fibers (black arrows) at 24 
hours of culture (Figure 2-2A).  This interaction of collagen fibers with sprout processes 
is evident in overlay images of SHG+TPF, where the invading ECs (green) track along 
collagen fibers (red). The collagen matrix presented a heterogeneous environment that 
must be navigated by ECs while exploring potential migratory routes.  Examination of 
ECs at higher magnification revealed that extended peripheral processes also appeared to 
intersect with collagen fibers (black arrows), at times extending processes beyond areas 
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of intersection (gray arrows) that extended further into the interstitial space (Figure 2-
2B).  
 
 
Figure 2- 1. Analysis of 3D EC invasion assays using light microscopy and NLOM.  (A) 
ECs were seeded on the upper surface of a collagen matrix as a monolayer (white 
arrowheads) and allowed to invade into underlying matrix over time. Four-day cultures 
were fixed with 4% paraformaldehyde and stained with toluidine blue gels were cut 
perpendicular to the monolayer to obtain several thin gel slices which were 
photographed using light microscopy. (B) Time-lapse analysis of live invading EC 
movement through collagen matrices starting at 30 (left panel) and 31 (right panel) 
hours. Collagen matrix alterations are indicated by black arrowheads. (C-E) TPF and 
SHG gathered using NLOM were compiled into 3D images at 18 (C, D) and 48 hours 
(E).  (D, E) False color was applied to show invading EC structures (green) within 
collagen matrix (red).  Extended peripheral sprout processes were observed to form 
along the leading edge of invading structures (gray arrows) as well as vacuolar structures 
(black arrow in E) initiating lumenal structures (dark open areas) indicated by black 
arrowhead.  Scale bar is 50 µm. 
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Figure 2- 2. Invading structures interact with collagen fibers and degrade collagen. (A) 
NLOM 2D images of collagen SHG and SHG + TPF overlay captured at 24 hours 
showed extended process (gray arrow) migrating along a fibrous collagen structure 
(black arrow). Scale bar is 20 µm.  (B) NLOM 3D reconstruction captured at 48 hours 
revealed extended peripheral processes from an invading structure (green) intersected 
with individual collagen fibers (red). Magnified window shows fine EC processes (gray 
arrows) circumventing individual collagen fibrils (black arrows).  (C) Individual NLOM 
sections of collagen SHG, TPF and their overlay (SHG+TPF) at 48 hours revealed a 
collagen-free space (red star) surrounded by an invading EC structure with an extended 
process (indicated by white arrows).  (D) 3D reconstruction from 700 sections at 0.5 µm 
intervals showing a tunnel within the collagen matrix (red) behind an invading EC 
structure. Panels 1-7 on right illustrate samples of individual 2D data sections used to 
compile the 3D stacked image from the approximate area outlined by white dashed lines. 
Scale bar is 50 µm. 
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Dissolution of 3D Collagen Fibers Occurs During Invasion 
      As invasion proceeds and ECs continue to advance through 3D collagen matrices, 
lumen formation is initiated. The formation of these structures and cell advancement 
coincided with the disappearance of collagen SHG signal (Figure 2-2C). Single optical 
sections of collagen fibers (SHG), the corresponding EGFP-expressing EC (TPF) and 
the overlay image (SHG+TPF) are shown.  These data revealed that establishment of an 
open lumen (dark area within TPF) resulted in dissolution or displacement of the 
collagen matrix as evidenced by a lack of SHG signal (red star). However, the 
cytoplasmic extension beyond the lumen (marked by white arrows) has not initiated 
dissolution or displacement of the collagen matrix. This is further illustrated in Figure 2-
2D, where portions of individual optical overlays (SHG+TPF) were compiled into a 3D 
stacked image (Figure 2-2D, left panel). Samples of the single optical sections used to 
compile the image are marked as panels 1-7. Dashed white lines indicate the area 
utilized from each image to compile the stack image, which captured a degraded ECM 
tunnel behind an invading structure.  
Collagen Matrices Are Reorganized During Cell Migration and Lumen Formation 
      In addition to collagen degradation or displacement, NLOM revealed that the 
composition and arrangement of collagen matrices was altered during invasion (Figure 
2-3). NLOM analyses of polymerized collagen matrices prior to addition of ECs 
revealed homogenous distribution of SHG signal and fibrous collagen (data not shown). 
Simultaneous acquisition of SHG and TPF images of invading structures revealed 
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increased SHG signal intensity between branch points of invading structures (Figure 2-
3A, white arrow). In addition to elevated collagen intensity that occurred between 
bifurcations of lumenal structures, we also observed increased collagen SHG intensity 
around the periphery of lumens (Figure 2-3B). Thus, NLOM provided evidence that as 
ECs invade into 3D collagen matrices, visible alterations occurred in the density and 
arrangement of fibrous collagen at the periphery of invading structures. Additionally, no 
collagen signal was detected inside the lumen, demonstrating that an ECM-free space 
exists within the lumenal compartment.   
      The elevated collagen SHG intensity observed may result from displacement or 
compaction of collagen fibers locally by the invading structure, or could be explained by 
collagen deposition. Analysis of ECs invading into 3D fibrin matrices at analogous times 
revealed no ability to detect deposition of fibrous collagen at bifurcations or at the 
periphery of invading structures (data not shown). These data suggest that increased 
collagen intensity at bifurcations and at the periphery of lumens is not the result of 
collagen deposition. 
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Figure 2- 3. Invading ECs alter collagen arrangement and increase collagen intensity at 
the periphery of lumens and at bifurcation points. (A) Single optical sections depicting 
increased collagen intensity near bifurcations of invading structures (white arrow). 
Lumens are the open dark areas in SHG lined by ECs (TPF). (B) Single optical sections 
depicting increased collagen intensity at the perimeter of an EC lumen. Images were 
taken after (A) 96 and (B) 108 hours of culture. Scale bar is 50 µm.   
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Quantification of Alterations in Collagen Matrix Density at Lumenal Branch 
Points 
      To ensure the observed alterations in collagen intensity were not due to 
heterogeneous distribution of fibrous collagen, we performed experiments comparing 
fibrous and homogenous 3D collagen matrices. Homogenous collagen matrices were 
useful in these experiments because SHG signals collected with NLOM were uniformly 
distributed and collagen fibers were not resolved. Fibrous and homogenous collagen 
matrices were prepared and analyzed to quantify and compare the increased collagen 
intensity observed near areas of lumenal branching. Single optical sections from 
invading structures in fibrous (Figure 2-4A) and homogeneous (Figure 2-4C) collagen 
environments illustrate that local increases in collagen matrix density coincide with 
lumenal bifurcation events in invading structures regardless of collagen structure. 
Quantification of the CIR values of collagen (SHG) signals (normalized to the average 
pixel intensity of the surrounding collagen matrix) and plotting these CIR  values using 
2D line scanned histographs revealed that the area with highest CIR coincided with the 
area between branching lumens for fibrous (Figure 2-4B) as well as homogeneous 
collagen matrices (Figure 2-4D).  Scanning lines are depicted in Figures 2-4A and C. 
The data demonstrate that the area between lumens exhibited increased density 
compared to the surrounding regions within the field of view for both fibrous (Figure 2-
4B) and homogeneous (Figure 2-4D) collagen matrices. Collectively, these data indicate 
that the NLOM signals are quantifiable and reveal increased CIR at areas of bifurcation 
between sprouting structures. 
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Figure 2- 4. Quantification of elevated Collagen Intensity Ratio (CIR) between 
bifurcations of invading structures revealed a 4-5 fold elevation within fibrous and 
homogenous collagen matrices compared with reference collagen intensity.  (A, C) 
Single optical sections collected at bifurcation points between invading structures in (A) 
fibrous and (C) homogenous collagen matrices. (B, D) Line scans (see gray arrows in 
panels A&C) quantify CIR along a single line in (A) fibrous and (C) homogeneous 
matrices.   
  
 52 
 
Extracellular Matrix Density Increased around Lumens of Invading Structures, 
but not Tips 
      In addition to bifurcation points, we consistently observed areas of elevated collagen 
intensity (increased SHG intensity) around the perimeter of open lumens (see Figure 2-
3B). To more precisely define the nature of the increased collagen density, we utilized 
homogenous 3D collagen matrices.  Data from seven independent invading structures 
were analyzed.  In the first series of experiments, peripheral CIR values were compared 
between lumens and invading tips (Figure 2-5). Two individual optical sections from the 
lumen and tip portions were selected from an invading structure. For individual sections, 
a vertical axis (V) was assigned as the morphologic symmetric axis and a perpendicular 
horizontal axis (H) was located at maximum lumen width (Figures 2-5A and 2-5B). The 
CIR values of lumen (LumenH, LumenV) and tip (TipH, TipV) were calculated at the cell 
periphery along horizontal and vertical axes to compare peripheral collagen intensities. 
In Figure 2-5C, analysis of seven individual invading structures showed similar trends 
where the CIR values of the horizontal and vertical axes at the lumen site were 
significantly greater than those at the tip site (P values are shown in Table 2-1). Among 
the data, CIR values at the periphery of lumenal structures were increased compared to 
the tip, which remained at or near one relative to overall or background collagen 
intensity. These data indicate that no appreciable differences were observed in local 
collagen concentration at the periphery of invading tips compared with the surrounding 
matrix.  
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Figure 2- 5. Quantification of the CIR at the periphery of invading structures revealed a 
significant increase around lumens but not tips. Representative NLOM sections are used 
for CIR quantification at the periphery of (A) lumens and (B) tips.  (C) Mean vertical 
(V) and horizontal (H) CIR based on average SHG values were calculated (see methods) 
and compared for seven individual samples. Data presented are average CIR values at 72 
hours +/- s.d. Statistical significance values are provided in Table 2-1. 
 
      Further examination revealed that the increased CIR associated with the formation of 
lumenal structures does not occur uniformly around the perimeter of lumens. To quantify 
this effect, CIR values at four end points of vertical (LumenV1 and LumenV2) and 
horizontal (LumenH1 and LumenH2) axes were compared to test whether the increased 
collagen intensity phenomenon was isotropically distributed. Analysis of seven 
individual invading structures (Figure 2-6) showed that the CIR values of the four end 
points were not equal, indicating that the observed increase in local collagen 
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concentration was anisotropic. Statistically significant differences were observed for 
individual data points (Table 2-2). Anisotropic matrix remodeling suggests that the 
lumenal compartment does not fill passively (i.e. like a balloon) and that an axis of 
lumen expansion exists. 
 
Figure 2- 6. Quantification of CIR at the periphery of lumens revealed an anisotropic 
distribution of collagen density. CIR values were calculated at four points (LumenH1, 
H2, V1 and V2), as shown in the legend and compared for seven individual samples (see 
methods). Data presented are average CIR values at 72 hours +/- s.d. Statistical 
significance values are provided in Table 2-2. 
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Figure 2- 7. Time-lapse analyses demonstrate that CIR is proportional to lumen 
diameter. (A) Single optical sections depicting SHG (left column), TPF (middle column) 
and overlay images (right column) at 36, 42, 48 and 60 hours. White arrows depict 
direction of lumen expansion. (B) Quantification of lumen size with time. (C) 
Quantification of the mean CIR around the lumen. Data values represent average CIR 
values at 4 points along the periphery of the lumen +/- s.d. as depicted in Figure 2-6. (D) 
Linear relationship between lumen size and mean CIR. Scale bar=50 µm. 
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Lumen Expansion is Associated with Elevated Collagen Intensity at Periphery 
      To investigate the relationship between lumen size and CIR at periphery of lumen, 
time-lapse analyses were performed. Invading structures were imaged with NLOM at the 
same focal plane at 36, 42, 48 and 60 hours as described in the methods. Lumen size was 
observed to expand, contract and/or maintain steady diameter. Elevated collagen 
intensities were observed in the direction of lumen expansion as indicated by arrows 
(Figure 2-7A). Lumen size and mean CIR at the periphery of lumens incrementally 
increased with time (Figures 2-7B and 2-7C, respectively).  A linear relationship was 
established (R=0.88661) between lumen size and mean CIR (Figure 2-7D), indicating 
that mean CIR at the periphery of lumens was proportional to lumen size. The linear 
relationship between lumen size and mean CIR was observed for both expanding and 
contracting lumens. 
 
Matrix Metalloproteinase Inhibition Increased Collagen Intensity Ratio at the 
Periphery of Lumens while Restricting Advancement of Invading Structures 
      To determine the role of the matrix metalloproteinases in modulating alterations in 
collagen matrix intensity at the periphery of lumen within advancing ECs, GM6001, a 
general matrix metalloproteinase inhibitor, was tested. Cultures were allowed to develop 
for 24 hours before being imaged with NLOM. Following image capture, cultures were 
treated with vehicle control (DMSO) or GM6001 and imaged again at the same focal 
depth at 48 hours (Figure 2-8).  Images from pre-treatment (24 hr) and post-treatment 
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(48hr) revealed inhibited expansion of the lumen in GM6001-treated cultures, but not 
control (Figure 2-8A). The addition of GM6001 successfully inhibited EC proteolysis as 
evidenced by a small enlargement in lumen size (Figure 2-8B). In addition, GM6001-
treated cultures demonstrated a reduced ability to invade (Figure 2-8C). Following 
GM6001 addition at 24 hours, the mean CIR increased significantly compared to 
controls at 48 hours (Figure 2-8D). Although an increase in mean CIR was observed in 
the control, the increase was more robust with GM6001 treatment. Quantification of the 
percent increase in lumen size and CIR is shown in Figure 2-8E. Lumen size increases 
were significantly greater in the control cultures compared to GM6001, while CIR was 
significantly higher following GM6001 treatment, compared to control. This indicated 
inhibition of proteolysis with GM6001 resulted in a small change in lumen diameter and 
a large change in CIR. This phenomenon is depicted by the collagen alteration index 
(CAI) value where change in CIR is normalized by change in lumen diameter (Figure 2-
8F).  
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Figure 2- 8. Addition of a global metalloproteinase inhibitor, GM6001 significantly 
increased CIR. Invading cultures were allowed to proceed for 24 hours before imaging 
invading structures (24 hr). Following image capture, 2.5 M GM6001 or Control 
(DMSO) was added. Cells were allowed to invade an additional 24 hours before the 
same structure was imaged (48 hr). (A) Single optical sections before and after GM6001 
or control treatment. Scale bar=50 µm. (B) Change in lumen size observed from 24 to 48 
hours and (C) average invasion distance of sprouting structures at 48 hours following 
GM6001 or control treatment. (D) Mean CIR observed at 24 and 48 hours. (E) Average 
percent increase in lumen size, and CIR. (F) Collagen alteration index, which is 
calculated as the percent increase in CIR divided by the percent increase in lumen size 
for control and GM6001 treatment. For data analyses, 6 structures were analyzed for 
control treatment and 8 for GM6001. Data presented are average values +/- s.d. Circles 
and stars indicate statistical significance observed when compared to 24 hour and 
GM6001 treatments, respectively. Filled symbols indicate p values < 0.05, open symbols 
indicate p <0.01, student’s t-test assuming unequal variance was applied. 
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Membrane-Associated Metalloproteinases are Responsible for Regulating Collagen 
Intensity at the Periphery of Lumens 
To determine which class of metalloproteinases is responsible for alterations in 
collagen intensity, endogenous inhibitors were applied. Tissue inhibitor of 
metalloproteinase (TIMP)-1 and TIMP-3 were selected because TIMP-1 is capable of 
inhibiting soluble MMPs while TIMP-3 inhibits membrane-associated forms as well as 
soluble MMPs [363]. Thus, the addition of TIMP-1 versus TIMP-3 can distinguish 
between the roles of soluble and membrane-associated MMPs in regulating collagen 
intensity at the periphery of lumens. Experiments were performed as described in Figure 
2-8.  While TIMP-1 allowed lumen expansion and appeared identical to control cultures, 
TIMP-3 prevented lumenal expansion (Figure 2-9A). In addition, invasion distance was 
significantly greater in control and TIMP-1-treated cultures compared to those treated 
with TIMP-3 after 48 hours (Figure 2-9B). These data are consistent with a previous 
report where TIMP-1 had no effect on EC invasion, but TIMP-3 completely inhibited 
[330]. The change in mean collagen intensity ratio (CIR) observed from 24 to 48 hours 
was similar in control and TIMP-1 treated cultures, while TIMP-3 treatment 
significantly increased the mean CIR (Figure 2-9C). The change of CIR level of TIMP-3 
was higher than that observed in control or TIMP-1 treatment. Plotting the percent 
increase in lumen size and CIR revealed a similar trend in control and TIMP-1, which 
exhibited a significantly higher increase in lumen size compared to the TIMP-3 treated 
group (Figure 2-9D). In contrast, TIMP-1 and control structures showed a smaller 
increase in mean CIR compared to TIMP-3. As shown in Figure 2-9E, the CAI value for  
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Figure 2- 9. Blocking membrane-associated, but not soluble, metalloproteinases 
increases CIR and CAI. Invading cultures were allowed to proceed for 24 hours before 
imaging invading structures. Following image capture, recombinant purified TIMP-1 or 
TIMP-3 was added, along with control buffer (M199). Cells were allowed to invade an 
additional 24 hours before the same structure was imaged (48hr). (A) Lumen size 
observed at 24 and 48 hours and (B) average invasion distance of sprouting structures at 
48 hours following TIMP-3, TIMP-1 or control treatment. (C) Mean collagen intensity 
ratio (CIR) observed at 24 and 48 hours. (D) Average percent increase in lumen size, and 
CIR. (E) Collagen alteration index, which is calculated as the percent increase in lumen 
size divided by the CIR for control, TIMP-1 and TIMP-3 treatment. For data analyses, 9 
structures were analyzed for control, 7 for TIMP-1 and 6 for TIMP-3 treatment. Data 
presentation and statistical analyses are identical to Figure 2-8. 
 
TIMP-3 was significantly greater than control or TIMP-1, which were comparable. 
These data reveal that treatment with TIMP-3 was consistent with GM6001 treatment, 
and indicate membrane-associated MMPs but not soluble MMPs are responsible for 
regulating collagen intensities at the periphery of invading ECs. 
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Endothelial Cell Traction Force Contributes to Collagen Matrix Alterations at the 
Periphery of Lumens 
      To determine whether cell traction forces are responsible for collagen matrix 
alterations around lumens, the Rho associated kinase (p160ROCK) inhibitor, H1152 was 
applied. The small GTPase Rho has previously been shown to mediate the generation of 
traction forces in endothelial cells through ROCK [24]. Cultures were allowed to 
develop for 48 hours before being imaged with NLOM. Following image capture, 
cultures were treated with vehicle control or H1152 (30 µM) and imaged again at the 
same focal depth at 72 hours (Figure 2-10).  Lumen expansion observed in control 
cultures was reduced with H1152 treatment (Figures 2-10A&B). Interestingly, H1152 
treatment decreased the CIR from 48 to 72 hours (Figure 2-10C), despite a slight lumen 
expansion. CIR increase was observed in control cultures. Plotting the percent increase 
in lumen size and CIR (Figure 2-10D), revealed an increase in lumen diameter and CIR 
for control cultures, consistent with data in Figures 2-8&9.  However, inhibition of 
ROCK resulted in a marginal increase in lumen size coupled with a decrease in CIR. As 
a result, the CAI differed dramatically between control and H1152 treatment (Figure 2-
10E). These data indicate that inhibition of ROCK decreased collagen matrix alterations 
at the periphery of lumens and that EC traction is responsible for regulating collagen 
intensity at the periphery of invading structures. 
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Figure 2- 10. p160ROCK inhibition with H1152 decreases CIR and CAI. Invading 
cultures were allowed to proceed for 48 hours before imaging invading structures. 
Following image capture, 30 M H1152 or control (water) was added. Cells were 
allowed to invade an additional 24 hours before the same structure was imaged (72 hr). 
(A) Single optical sections before and after H1152 or control treatment. Scale bar=50 
µm. (B) Lumen size observed at 48 and 72 hours. (C) Mean CIR observed at 48 and 72 
hours. (D) Average percent increase in lumen size and CIR. (E) Collagen alteration 
index (CAI), which is calculated as the percent increase in CIR divided by the percent 
increase in lumen size for control and H1152 treatment. For data analyses, 10 structures 
were analyzed for control H1152 treatment. Circles and stars indicate statistical 
significance observed when compared to 48hour and H1152 treatments, respectively. 
Filled symbols indicate p values < 0.05, open symbols indicate p <0.01, student’s t-test 
assuming equal variance was applied. 
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      To determine whether the enhanced collagen matrix alterations observed as a result 
of MMP inhibition were modulated by p160ROCK blockade, H1152 was applied to 
cultures pretreated with GM6001. In these experiments, cultures were allowed to 
develop for 24 hours before being imaged with NLOM. Following image capture, 
cultures were treated for another 24 hours with GM6001 and imaged at the same focal 
depth at 48 hours.  The cultures were next treated with vehicle control or H1152 (30 
µM) and imaged again at 72 hours (Figure 2-11). Following GM6001 treatment, from 24 
to 48 hours, a 20% increase in lumen size and 50% increase in CIR was observed, 
consistent with previous data (Figure 2-8). Treatment with H1152 from 48-72 hours 
decreased lumen expansion somewhat (Figures 2-11B), but significantly reduced the 
CIR (Figure 2-11C) compared to GM6001 treatment alone. Plotting the percent increase 
in lumen size and CIR from 48 to 72 hours (Figure 2-11D), revealed an increase in 
lumen diameter and CIR for GM6001-treated cultures.  Inhibition of ROCK from 48 to 
72 hours resulted in a negligible increase in lumen size and a decrease in CIR. Thus, the 
CAI values differed dramatically between control and H1152 treatment, with H1152 
increasing the ratio dramatically. This result demonstrates that ECs engage both 
membrane-associated MMPs and traction to ensure matrix accommodation and lumen 
expansion. 
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Figure 2- 11. p160ROCK inhibition relaxes CIR and CAI observed with proteinase 
inhibition. 3D cultures were established for 24 hours before invading structures were 
imaged. 2.5 µM GM6001 was then added and incubated from 24-48 hours. Cultures 
were imaged with NLOM at the same focal depth at 48 hours before adding H1152 (30 
µM) or control (water). Cells were allowed to invade until 72hr when the same 
structures were imaged for the final time. (A) Single SHG optical sections at 24, 48 and 
72 hours. Scale bar=50 µm. (B) Lumen sizes observed from 24 to 72 hours. (C) Mean 
CIR observed from 24 to  72 hours. (D) Average percent increase in lumen size and CIR 
from 48 to 72 hours. (E) Collagen alteration index (CAI), which is calculated as the 
percent increase in CIR divided by the percent increase in lumen size for control and 
H1152 treatment from 48 to 72 hours. Data presented are average values +/- s.d. For data 
analyses, 9 structures were analyzed for GM6001 treatment and 9 for GM6001+H1152. 
Circles and stars indicate statistical significance observed when compared to 48hour and 
H1152 treatments, respectively. Filled symbols indicate p values < 0.05, open symbols 
indicate p <0.01, student’s t-test assuming equal variance was applied. 
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Discussion 
 
      In this study, we utilized NLOM to more closely define interactions between 
invading ECs and 3D collagen matrices. Our data demonstrated that extended peripheral 
processes of invading ECs migrated along intact collagen fibers, frequently 
circumventing them to continue migrating through the matrix. In addition, the presence 
of lumenal structures coincided with collagen dissolution or displacement as evidenced 
by the disappearance of SHG signal. Finally, invading EC structures leave behind tracks 
or tunnels that are devoid of ECM. Interestingly, the density of collagen is significantly 
anisotropically altered in surrounding areas of lumen formation, suggesting collagen 
matrix displacement or compaction. Furthermore, elevated collagen intensity was 
observed at areas associated with branching of lumenal structures. The high sensitivity 
and specificity of NLOM indicating the collagen matrix revealed a non-homogeneous 
environment within which invading ECs navigated and remodeled. These findings open 
the possibility that the heterogeneous matrix may influence and even guide or direct 
invasion.  Time-lapse data from NLOM demonstrated lumen expansion was associated 
with elevated local collagen concentration. Global matrix metalloproteinase inhibition 
with GM6001 resulted in a significant increase in collagen intensity at the periphery of 
lumens that was reproduced with TIMP-3, but not TIMP-1 treatment. These data 
indicate that collagen intensity alterations are determined by membrane-associated, but 
not soluble MMPs. Inhibiting p160ROCK, which mediates the generation of traction 
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forces by endothelial [24] and other cells [364], decreased lumen expansion and collagen 
intensity ratios compared to control treatment. Pretreatment with metalloproteinases 
elevated CIR that could be reduced by p160ROCK inhibition, revealing that a balance 
between proteolysis and force generation dictates ECM organization at the periphery of 
invading structures. 
      We observed a strong correlation between collagen fiber orientation and sprout 
outgrowth. ECs tracked along existing fibrous collagen (Figure 2-2A) as well as 
intersecting with and extending processes beyond collagen bundles (Figure 2-2B). These 
data are consistent with a previous report demonstrating radiating collagen fibers at the 
periphery of tumors and local cell invasion that predominantly occurred along aligned 
collagen fibers in vivo [340], that was confirmed by  manipulating collagen fiber 
orientation [343]. Further, cultured tumor explants can realign collagen fibers, allowing 
individual tumor cells to migrate radially along aligned fibers [340]. Bud formation in 
the mammary gland may occur in a similar manner, with long bundles of collagen fibers 
that radiate from terminal buds to influence ductal outgrowth and patterning [344]. 
These observations are consistent with findings by Utzinger and colleagues who 
observed angiogenic sprout outgrowth from microvessel fragments embedded in 3D 
collagen matrices [346]. Collagen fibril architecture was observed to be aligned along 
the direction of sprout outgrowth, suggesting that sprouting angiogenic structures may 
also exert tension on and reorganize the matrix as they advance [346]. Although we do 
not observe overt collagen alterations at the tips of outgrowing ECs, the possibility 
remains that the arrangement of collagen fibers may be altered by ECs protrusions as 
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invasion proceeds. Time lapse imaging is currently underway to definitively determine 
whether sprouts simply sense or rearrange collagen fibers as invasion proceeds.  
Regardless, these EC-ECM interactions cannot be appreciated in traditional 2D culture 
systems.   
      Increased matrix stiffness can modulate EC morphogenesis, where cells tested with 
increased matrix rigidity formed larger lumens [20, 133, 253, 271, 365, 366] 
demonstrating that ECs, much like fibroblasts [318, 367, 368] respond to alterations in 
matrix tension. Unlike fibroblasts, which respond by increasing contractile properties 
and can differentiate into myofibroblasts [369], ECs respond to increase in matrix 
tension by increasing lumen diameter [271], a process that is mediated through 
membrane-associated metalloproteinase activity [333]. Our data reveal that advancement 
of invading structures resulted in cell-mediated anisotropic increases in collagen matrix 
intensity at the periphery of lumens. This may generate specific mechanical cues for 
continual remodeling of the advancing sprout via localized proteolysis required for 
continual expansion of the lumen. Experiments employing metalloproteinase inhibition 
resulted in increased collagen intensity around the lumen and limited sprout 
advancement. Thus, the balance between generation of matrix tension and initiation of 
proteolytic events must be exquisitely controlled to ensure sprout development. We 
speculate this balance serves to efficiently deliver nutrients to surrounding tissue, 
because increased collagen density can be a diffusive barrier for macromolecular 
transport. 
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      ECs respond to biochemical cues such as matrix attachment sites, angiogenic growth 
factors and shear stress [370-372], but substantial evidence also demonstrates that 
mechanical signals within the matrix can affect cell behavior and morphogenic 
responses. Our data demonstrate that collagen matrices are anisotropically altered at the 
periphery of lumens, indicating that the cell-mediated forces that are applied to the 
periphery of the invading structure are not uniform and these alterations may affect 
subsequent development of the advancing structure. Because vacuole formation, fusion 
and coalescence are prerequisites for lumen formation in endothelial and epithelial 
systems [373, 374], vacuolar trafficking during lumen formation may be directed by 
matrix alterations observed at the periphery. ECM remodeling is a dynamic process 
involving integrins and proteases. Integrins, the primary ECM receptors mediating ECM 
remodeling [375], act as mechanotransducers and can transfer mechanical force from the 
cell to ECM or vice versa [376], and likewise control vacuole formation events [261]. In 
addition to vacuolar trafficking, cell-derived tension within the collagen matrix could 
also control vascular compliance. Cells are capable of exerting tension to realign 
collagen fibers while migrating through 3D ECM [364, 377-379]. The elevated collagen 
intensity at the bifurcation area of lumens (Figure 2-4) is indicative of increased collagen 
density and hence increased rigidity. This could be a contributing factor as to why 
atherosclerotic plaques tend to occur at the bifurcation of aorta, carotid and coronary 
arteries [380] since arterial compliance, a diagnostic marker for plaque [381], is 
associated with ECM rigidity [382]. At the present time, the functional significance of 
collagen matrix alterations remains undefined. 
 69 
 
      Endothelial sprouting requires proteinases. Our data demonstrate that soluble MMPs 
do not play a role in sprouting events because TIMP-1-treated cultures invade similarly 
to control, while the addition of TIMP-3 limits lumenal expansion and invasion in 
established invading structures. It is well-established that MT1-MMP is required for 
endothelial sprouting responses and lumen formation [80, 96, 332, 333]. In addition, 
MT1-MMP is utilized by tumor cells for outgrowth in three dimensions [383]. Thus, 
MT1-MMP is a key enzyme that degrades type I collagen and mediates cell movement 
in three dimensions. Friedl and colleagues have demonstrated that proteolytic activity 
localizes to the middle portion of a tumor cell migrating in 3D. This scenario is 
consistent with our observations, where increased collagen intensity is observed at the 
periphery of lumens, analogous to what has been described as the ‘stalk’ of a newly-
forming angiogenic vessel [384]. The time-lapse data presented demonstrated that 
increased CIR was directly proportional to lumenal expansion, an event that is dependent 
on MT1-MMP activity [333].  By inhibiting membrane-associated MMPs using TIMP-3 
or GM6001, we observed elevated CIR at the periphery of lumens compared to non-
treated and TIMP-1 controls. These data argue that the elevated CIR resulting from 
decreased collagen proteolysis was due to increased interactions between ECs and the 
surrounding collagen matrix and tension exerted on the web of ECM by the invading 
ECs. In the absence of proteolysis, cell-matrix interactive forces act on the surrounding 
collagen matrix to increase force generation, traction and tension, visualized at the cell 
periphery as an increase in collagen intensity. These forces are likely generated 
circumferentially via integrin receptors and the cytoskeleton. Consistent with this idea, 
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SHG imaging of mammary glands in vivo revealed increased collagen intensity at the 
periphery of glandular structures compared to the surrounding ECM [340]. In addition, 
our observations were consistent with data collected from neovessel outgrowth from 
microvessel explants in collagen matrices, as well as undigested microvessels [346], 
where collagen aligned asymmetrically along the base of invading sprouts, but was less 
apparent and not different from surrounding matrix at the leading edge. Our studies 
utilizing Rho kinase inhibition support this contention, where blocking Rho kinase and 
the subsequent ability to generate tension resulted in a significant decrease in collagen 
intensity ratio, and thus, a change in the distribution and organization of collagen fibers. 
A similar phenomenon has recently been reported to be required for outgrowth of tumor 
explants [343]. Further investigation of the specific nature of these regions of compacted 
or compressed collagen is warranted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 71 
 
CHAPTER III 
ANGIOGENIC RESPONSES TO MECHANICALLY AND MICROSCOPICALLY 
CHARACTERIZED, MICROBIAL TRANSGLUTAMINASE CROSS-LINKED 
COLLAGEN MATRICES 
 
Overview 
 
      Sprouting endothelial cells (ECs) use both soluble and insoluble cues to guide 
migration and expand the existing vascular network to meet changing trophic needs of 
the tissue during angiogenesis.  Fundamental to this expansion are physical interactions 
between ECs and extracellular matrix (ECM) that influence sprout migration, lumen 
formation and stabilization.  These physical interactions suggest that ECM mechanical 
properties may influence sprouting ECs and, therefore, angiogenic responses.  In a 3D 
model of angiogenesis in which a monolayer of ECs is induced to invade an underlying 
collagen matrix, we measure angiogenic responses as a function of collagen matrix 
stiffness by inducing collagen cross-linking with microbial transglutaminase (mTG).  
With biaxial mechanical testing, we show that collagen matrices stiffen with both mTG 
treatment and incubation time.  Using two-photon excited fluorescence (TPF) and 
second harmonic generation (SHG), we show collagen TPF intensity increases with 
mTG treatment and that the ratio of TPF/SHG correlates with biaxial tested mechanical 
stiffness.  SHG and optical coherence microscopy (OCM) are further used to show that 
other physical properties of the matrix such as porosity and pore size do not change with 
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mTG treatment, thus providing the same density but different stiffness with which to 
measure angiogenic responses.  Our results showed that stiffer matrices promote 
angiogenesis, measured by more invading sprouts that invade deeper.  No differences in 
lumen size were observed between control and mTG stiffened 3D cultures, but there was 
evidence of greater matrix remodeling in stiffer gels using NLOM.  Results of this study 
show angiogenic responses are enhanced with increasing stiffness and suggest that these 
properties may be used in tissue engineering and regenerative medicine applications to 
engineer angiogenesis. 
 
Introduction 
 
      Angiogenesis, new blood vessel formation from existing structures, is necessary for 
normal physiological growth and developmental processes ranging from embryogenesis 
to wound healing, and pathologic processes ranging from psoriasis, cancer, rheumatoid 
arthritis, ischemia, inflammation and various cardiovascular diseases [323, 324, 385]. 
Cell migration, proliferation, intracellular alignment, adhesion, and lumen formation are 
coordinated cellular actions that enable ECs of existing vessels to detach from the 
vascular wall, degrade and penetrate the underlying basal lamina while invading the 
surrounding 3D interstitial ECM during angiogenesis [325-327]. These processes are 
regulated by biochemical and biophysical cues. The ECM is a scaffold that provides 
mechanical support and adhesive contact sites, along with mechanical signals, that 
combine with biochemical cues to promote angiogenesis.   
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      Cell movement through 3D matrices is a precisely coordinated process. Growth 
factors and lipids, such as sphingosine-1-phosphate, deliver potent pro-angiogenic 
signals [270, 328, 329, 386] that stimulate endothelial outgrowth and invasion events 
and require membrane-associated (but not soluble) matrix metalloproteinases (MMPs) 
[330].  In particular, these events require MT1-MMP [331, 332, 387], which selectively 
and locally degrades ECM proteins at the cell surface-ECM interface without affecting 
the integrity of the ECM scaffold. Thus, newly-sprouting endothelial cells integrate 
signals from pro-angiogenic stimuli to initiate successful outgrowth in 3D matrices.  
      ECM stiffness influences various pathological diseases, such as cancer and 
atherosclerosis [283, 388]. How ECM stiffness influences cell behavior [309, 389] has 
been investigated in vitro among different cell types, including ECs [271, 318, 390, 
391], smooth muscle cells [135, 392, 393], fibroblasts [113, 134, 318, 394], 
macrophages [395], leukocytes [391, 396], tumor cells [397-399] and stem cells [117, 
400]. Substrate stiffness controls cell characteristics including, the size of focal 
adhesions, cell stiffness [397, 401] and traction forces generated by the cell [394, 397, 
401]. The influence of ECM stiffness on angiogenesis has been investigated in several 
2D [138] and 3D [133, 136, 137, 162, 195, 271, 273, 366, 402-405] in vitro studies. 
Among them, most 3D studies tuned ECM stiffness by changing protein concentration of 
various ECM including collagen [162, 271, 404, 405] and fibrinogen [136, 137, 273, 
366, 403]. However, changing ECM protein concentration will not only change bulk 
mechanical properties (i.e. stiffness) but also change its topographical properties (i.e. 
 74 
 
porosity, pore size, and fiber thickness). Therefore, decoupling ECM mechanical 
properties from its topographical properties remains a challenge. 
      3D ECM scaffolds can be created with synthetic polymers, such as polyethylene 
glycol (PEG) [132] or natural polymeric materials, such as collagen, fibrin, hyaluronan. 
The advantages of natural materials over synthetic materials are that natural materials 
are viscoelastic, biodegradable and contain natural ligands [406]. Type I collagen, the 
major collagen found in skin and bones, dominates 90% of total collagen present in the 
body and is the natural material most often used for creating 3D scaffolds. Collagen is 
also a strong promoter of EC morphogenesis [195]. The microstructure, biophysical 
properties and gelation kinematics of collagen can be tuned by controlling concentration 
[158-161], temperature [159, 163-165], ionic strength [161], phosphate content and pH 
[133, 159, 163, 166] during collagen fibrillogenesis. In order to decouple stiffness from 
topographical properties, tuning stiffness via concentration is not an option. Without 
changing collagen concentration, collagen scaffold stiffness can be strengthened via 
crosslinking collagen physically [174-176], chemically (glutaraldehyde [163, 177, 178] 
and carbodiimide [181-183]), enzymatically (tissue transglutaminase tTG [67, 68][186, 
187], microbial transglutaminase [185, 188], lysyl oxidase [189]) and non-enzymatically 
(glycation [190-194]). Even tissue transglutaminase and lysyl oxidase are physiologic, 
more merits [199, 200] of using mTG over tTG are Ca2+ independent, higher reaction 
rate and broader substrate specificity. How the topographical properties of the ECM 
microstructure influenced by mTG can be characterized with our NLOM-OCM 
combined system. 
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      Nonlinear optical microscopy (NLOM) provides spatial and temporal information of 
ECs-matrix interactions during angiogenesis noninvasively and nondestructively [407] 
with evidence of its 3D high resolution imaging with no out-of-focus scattering, minimal 
photo-bleaching, reduced light scattering and deeper tissue penetration when compared 
with confocal microscopy [209]. Owing to lack of cetrosymmetric center, collagen has 
appreciable nonlinear susceptibility for second harmonic generation (SHG) [243, 334-
339], a nonabsorptive process, and that property enables application of NLOM in 
collagen scaffold microstructure without using exogenous stains or dyes [165, 166, 229-
233, 338]. The fluorescence from collagen depends on organization of collagen fibrils, 
the amount of cross-linked fibers [165, 230-232] and polymerization time [229]. NLOM 
has been applied to characterize optical properties of collagen treated with various cross-
linkers including glutaraldehyde [165, 230], glycation [232] and genipin [231]. The 
effects of mTG-induced collagen cross-linking in the optical properties of collagen 
matrices have not been investigated to date. 
      Here, we utilized an in vitro model [330] that mimics the sprouting step of 
angiogenesis where ECs are allowed to invade in 3D collagen matrices. We used a 
NLOM-OCM combined system to investigate the mechanical and optical properties as 
well as the microstructure (topographical properties) of mTG-treated collagen and 
successfully decoupled stiffness from topographical properties. Our experiment results 
revealed that ECM stiffness induced by mTG treatment enhanced angiogenic responses. 
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Materials and Methods 
 
Reagents and Chemicals      
      Type I rat-tail Collagen was obtained from BD Biosciences (San Jose, CA). 
Recombinant human vascular endothelial growth factor (VEGF) and fibroblast growth 
factor-2 (FGF-2) were purchased from R&D Systems (Minneapolis, MN). Medium 199 
(M199) and fetal bovine serum (FBS) were purchased from Invitrogen (Grand Island, 
NY). Tumor promoting antigen (TPA, Phorbol 12-myristate 13-acetate) (what was TPA 
used for?) and ascorbic acid (AA) were purchased from Sigma (St. Louis, MO). 
Sphingosine-1-phosphate (S1P) was purchased from Avanti Polar Lipids (Alabaster, 
AL). ACTIVA WM, a gift from Ajinomoto (Japan), was derived from Sreptoverticilium 
mobaraense and mTG (39 kDa) was obtained with further purification of ACTIVA WM 
to remove maltodextrin (2.3-3 kDa). mTG has a higher specific activity to crosslink 
collagen over a wider range of temperature and pH and its activity is Ca2+ independent. 
ACTIVA WM was dissolved in ice-cold 50 mM sodium phosphate buffer (pH 6.0) and 
then dialyzed against 20 mM sodium acetate (pH 5.5) three times at 3 hour intervals 
before centrifugation at 3000 G for 30 min to collect the supernatant. Supernatant was 
loaded to a 50 ml SP Sepharose (Sigma) column with a continuous flow rate of 5 
ml/min. Column was washed and protein eluted at the same flow rate with NaCl gradient 
from 0 mM to 500 mM in 20 mM sodium acetate buffer (pH 5.5). Fractions containing 
mTG were determined from Coormassie Stain, pooled together and dialyzed against 
distilled autoclaved water three times at 3 hour intervals. Dialyzed product was 
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lyophilized, weighted, dissolved with M199 with final concentration determined with 
BCA protein assay and stored at -70ºC for long term storage. 
Cell Culture 
      Primary human umbilical vein endothelial cells (HUVECs) were purchased from 
Cambrex and used at passage 2-6. ECs were grown on gelatin-coated tissue culture 
flasks (1 mg/ml) in culture media of M199 containing 15% FBS, 400 µg/ml bovine 
hypothalamic extract [359], 100 µg/ml heparin (Sigma), 0.1% gentamycin and 1% 
penicillin/streptomycin (Invitrogen). Cells were passaged once a week. EC lines stably 
expressing enhanced green fluorescent protein (EGFP) were generated using a 
recombinant lentivirus system (Invitrogen) [407]. 
Collagen Gel for Optical and Mechanical Properties Measurement and Angiogenic 
Evaluation 
      Fibrous collagen gels were formed with rat-tail type I collagen, 5X DMEM, 
reconstitution buffer, neutralized with 1M NaOH [339] and mTG to create 3.5 mg/ml 
collagen matrices with final mTG concentrations of 0, 100 and 500 µg/ml. Cruciform 
shaped acellular collagen gels, used for optical and mechanical properties measurements, 
were formed within a cruciform shaped mold. Ice-cold collagen-mTG mixture mixed 
with beads was placed within the mold inside incubator for 12 hours for polymerization. 
The acellular gels were covered with 200 ml M199 until imaging with NLOM-OCM 
combined system and mechanical testing with biaxial bioreactor. For EC invasion 
studies, the collagen-mTG mixture containing 1 µM S1P 80 µl per well, used for 3D 
angiogenesis assay, was polymerized in 96-well plate in 37 ºC and 5% CO2 incubator for 
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12 hours. After washing three times with sterile 160 µl M199 at 10 min intervals, 3D 
angiogenesis invasion assays were generated by seeding an EC monolayer on the 3D 
collagen surface with cell density of 7x104 per well of 96 well plate in serum-free M199 
containing reduced serum supplement II (RSII) [360], recombinant VEGF (40 ng/ml), 
recombinant FGF (40 ng/ml), AA (50 µg/ml) and TPA (50 ng/ml). Cultures were 
allowed to proceed for the times indicated before fixing in 4% paraformaldehyde in PBS 
prior to imaging. 
Nonlinear Optical Microscopy-Optical Coherence Microscopy (NLOM-OCM) 
Combined System    
System setup     
      Our custom-built NLOM-OCM combined system has been described previously 
[408].  Briefly, dispersion-compensated sub-10-fs pulses (800 nm, FWHM=133 nm) 
from a Ti:Al2O3 oscillator (Femtosource, Femtolasers) pumped by a Nd:YVO4 solid 
state laser (Verdi, Coherent) were split by 10/90 beam splitter. One beam (sample arm) 
was coupled into the epi-fluorescence port of  an upright microscope (Axioskop2 MAT, 
Carl Zeiss GmBH) via dual-axis galvanometer driven mirrors (Model 6220, Cambridge 
Technology) mounted on an elevated breadboard and the other beam was used as 
reference arm.  The beam in sample arm was directed to the microscope objective by a 
short pass dichroic mirror (635dcspxruv3p, Chroma).  Nonlinear optical signals were 
collected by the 40x focusing objective (NA=0.8) and directed to a custom built two 
channel detector unit mounted on one of the dual accessory ports of the binocular head.  
The detector unit housed two dichroic mirrors and bandpass filters (Chroma), focusing 
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lenses (PCX, focal length: 50 mm, 31 2321, Linos Photonics), and a pair of photon-
counting photomultiplier tubes (R7400P, Hamamatsu). Appropriate long pass dichroic 
mirrors and bandpass filters were used for SHG (430dcxru and HQ405/40, respectively; 
Chroma) and TPF detection (580dcxr and HQ480/40, respectively; Chroma).  In imaging 
mode each photomultiplier tube was connected to a preamplifier/discriminator (F-100T, 
Advanced Research Technologies) that thresholds signal current and converts to TTL 
pulses for photon counting.  Image intensities were displayed in photon counts on a PC 
(Optiplex GX280, Dell). For OCM, simultaneous backscatter laser light in sample arm 
was combined with return light from reference arm and focused into single mode optical 
fiber which directed into a home-made spectrometer for Fourier domain detection. 
Throughout this experiment, less than 40mW of laser power was incident on the 
scanning mirrors, approximately 10 mW at the sample.  
Image acquisition and analysis       
      Samples of cruciform shaped acellular collagen gels or of 3D angiogenesis assays 
were imaged without stains using NLOM-OCM combined system rendering en face, 2D 
images with integrated intensities of 4 scans at each focal depth. A stack of images was 
generated by incrementally changing the depth of focus. For acellular matrices, five 
image stacks were acquired at least 1 mm distance apart and each stack contained 10 
images at depth from 10 µm to 100 µm below gel surface. For 3D angiogenesis assay, 
image stacks with 5 µm increment were acquired from structures containing lumens 
from monolayer to sprout tip. SHG, TPF and backscatterred OCM signals were collected 
simultaneously with NLOM-OCM combined system. Image files acquired from NLOM 
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were converted from 16-bit to 8-bit files via MATLAB by scaling the maximum pixel 
value to 255.  
Optical properties and topographical properties of acellular matrices     
      Fuzzy thresholding algorithm written with MATLAB code was applied on SHG 
images to create binary masks of collagen fibers. The automated custom MATLAB 
algorithm includes steps of increasing dynamic range of image with intensity 
transformation, smoothing image with fuzzy transformation and finally based on 
histogram of smoothing image to create binary mask which corresponds to collagen 
fibers [409]. With binary mask of SHG (collagen fibers), porosity, pore size and pore 
number could be quantified with MATLAB software. Negative binary mask was used to 
highlight the void region or pore locations and porosity was calculated by void region 
pixel number to total pixel number of 256x256 in a value between 0 and 1. Number of 
void regions was reported as pore number. Pore size was acquired from converting pixel 
number of average void region area into actual area size with unit of µm2. Segmented 
SHG and TPF for optical properties quantification of acellular matrix could be created 
with SHG and TPF images multiplied by collagen fiber binary mask, therefore, only 
SHG, TPF intensities from collagen fibers will be used for quantification. Normalized 
segmented SHG and TPF were created with normalizing pixel intensities in segmented 
SHG and TPF to its corresponding background noise after obtaining background noise 
of SHG and TPF from averaging the signal intensities of SHG and TPF among all void 
region (pore) from negative collagen binary mask. Optical properties, such as SHG 
mean, TPF mean and SHG/TPF ratio, could be calculated after obtaining pixel 
 81 
 
intensities of normalized segmented SHG and TPF. SHG mean and TPF mean are 
defined with total pixel intensities in normalized segmented SHG and TPF divided by 
total pixels of collagen fibers respectively. TPF/SHG ratio is calculated with averaging 
pixel-wise TPF/SHG ratio of normalized segmented TPF over SHG on area with 
collagen fibers.  
Lumen area and collagen intensity ratio     
      Binary masks of TPF images to reveal lumen boundary were created with the same 
algorithms used for SHG binary mask creation. The combination of binary masks of 
SHG and TPF was used for selecting the lumen of interest to create binary lumen mask. 
Lumen area in µm2 was calculated by converting total pixel numbers of lumen into 
actual lumen size with known value of actual area per pixel. Collagen intensity ratio 
(CIR) from SHG (or OCM) was calculated from averaging the normalized segmented 
SHG (or OCM) intensities inside the ring area with inner circumference equaled to 
lumen area and ring thickness equaled to lumen wall thickness.          
Biaxial Bioreactor for Mechanical Properties Measurements 
      After imaging with NLOM-OCM combined system, the cruciform shaped gel was 
coupled to loading carriage of biaxial bioreactor filled with 1x phosphate buffer saline 
(Sigma). The bioreactor was transferred onto a testing platform containing two force 
transducers for force recording, four computer controlled step motors and one CCD 
camera on top for strain measurement based on tracing beads movement ([410], Bai et 
al.[in submission]). The data of load-stretch ratio curve was reported after 3rd cycle 
since the preconditioning condition could be achieved after 3rd cycle (data not shown). 
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Transmitted Light Image Acquisition and Quantification   
      3D angiogenesis cultures were fixed in 3% glutaraldehyde in PBS and stained with 
toluidine blue as previously described [330]. Invading structure number per field of view 
was acquired under 10X objective. To quantify invasion distance, photographs of 
invading cells were taken from a side view with an Olympus CKX41 microscope 
equipped with a Q color 3 Olympus camera. Invasion distance and lumen diameter 
measurement were measured digitally using Image Pro Analyzer software. 
 
Statistics 
 
      Student’s T-tests were applied in statistics evaluation among studies of optical 
properties, topographical properties and angiogenic responses and significant differences 
were labeled or tabulated in Figure 3-2, Figure 3-6, Figure 3-8, Figure 3-9, Figure 3-12 
and Figure 3-13.  P-value < 0.05 was considered a significant difference. 
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Results 
 
Nonlinear Mechanical and Optical Properties of mTG Cross-linked Collagen 
Matrices 
      In this study, we sought to characterize angiogenic responses as a function of 3D 
collagen matrix stiffness while keeping density constant. To accomplish this, we 
crosslinked 3.5 mg/ml collagen gels with mTG and reasoned, (and later confirmed,) that 
by holding density constant, other microstructural properties such as porosity would not 
change. Cruciform-shaped collagen gels (3.5 mg/ml) were mechanically tested in our 
custom biaxial bioreactor. Graphs of load (g) as a function of strain are shown in Figure 
3-1 for collagen gels treated with mTG (control, 100, 500 μg/ml) and incubated for 1 
(Figure 3-1A), 2 (Figure 3-1B) and 7 days (Figure 3-1C). The mechanical testing curves 
exhibited nonlinear and viscoelastic responses characteristic of soft tissues. For each 
day, load (g) to stretch gel 5% increased with mTG dose, and load magnitude increased 
with each day of measurement. Collagen gels treated with 500 µg/ml mTG were 
consistently stiffer than all other treatment groups. On Day 1, loads at 5% stretch were 
1.87, 2.44, and 3.69 g for control, 100, and 500 µg/ml mTG treated collagen gels, 
respectively (see Figure 3-1A). On Day 2 (Figure 3-1B), loads at 5% stretch were 2.07, 
2.29, and 4.66 g for control, 100, and 500 µg/ml mTG, respectively, indicating an 
increase in load for control as well as mTG treated gels. On Day 7, these trends 
continued with loads at 5% stretch of 2.70 and 10.18 g for control and 500 µg/ml mTG 
treated gels, respectively.  
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Figure 3- 1. Biaxial mechanical tests of acellular cruciform-shaped collagen gels 
revealed nonlinear viscous response curves with larger loads for higher mTG doses and 
incubation times. Load (g)-strain curves of control and mTG-treated collagen gels tested 
on Day 1 (A) and Day 2 (B), and Day 7 (C). Note changes in scale of Load (g) axes. 
 
      Our NLOM-OCM combined system is sensitive to endogenous collagen signals, 
two-photon excited fluorescence (TPF) and second harmonic generation (SHG), 
enabling simultaneous visualization of both to better characterize collagen nonlinear 
optical properties. Collagen TPF has previously been shown to correlate with cross-
linking [229], of which one fluorescent cross-link is reportedly pryridinoline [411]. 
Collagen SHG results from the mixing of light within its quasicrystalline structure and is 
thus sensitive to molecular order and collagen higher order structures [243, 339].  
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Figure 3- 2. TPF/SHG ratio correlates with mTG dose and incubation time. (A) 
Representative TPF and SHG images of control and mTG-treated acellular collagen 
ECM at Day 1 and Day 7. Plots of TPF/SHG ratio (B) of collagen as a function of mTG 
dose treatment and incubation time.  In statistics table, region highlighted with black 
color represents for significant difference with p<0.05. Error bars represent mean +/- 
STD. Scale bar is 50 µm. 
 
      SHG and TPF images of acellular collagen matrices were collected at Day 1 and 7 of 
control and mTG treated gels (Figure 3-2A). Under each condition, collagen TPF 
intensity was noticeably higher on Day 7 than on Day 1. Quantification of SHG and TPF 
images revealed that TPF and TPF/SHG in mTG treated gels was enhanced with dose up 
to 500 µg/ml but not SHG, see Figure 3-2B (TPF, SHG data not shown). Consistent with 
mechanical testing results, measurements of TPF to SHG ratio increased from Day 1 to 
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Day 7. On each day (Day 1, Day 2, and Day 7), TPF/SHG ratio increased with mTG 
dose and peaked at 500 µg/ml mTG treatment (Figure 3-2B) with significant difference 
compared to control. On Day 1, TPF/SHG of acellular collagen increased from 
0.083±0.004 for control to 0.085±0.003 and 0.115±0.003 when treated with 100 and 500 
µg/ml mTG, respectively. On Day 2, TPF/SHG exhibited a similar trend as Day 1 with 
values of 0.081±0.003 for control and 0.096±0.005 and 0.119±0.006 for 100 and 500 
µg/ml mTG treated gels, respectively. The most prominent difference in collagen 
TPF/SHG ratio was observed at Day 7, where TPF/SHG values nearly doubled from 
Day 1. Collagen TPF/SHG ratios measured on Day 7 were 0.142±0.007, 0.153±0.005 
and 0.212±0.008 for control, 100, and 500 µg/ml mTG treated gels, respectively. 
      If collagen TPF/SHG ratio did correlate with collagen cross-linking level, then the 
optical measurement should correlate with the mechanical response measurement. As an 
indicator of collagen mechanical properties, we used load (g) at 5% stretch. Correlative 
plots were shown in Figure 3-3 of load (g) at 5% stretch with SHG (Figure 3-3A), TPF 
(Figure 3-3B), and TPF/SHG (Figure 3-3C). Consistent with previous work [229], SHG 
was observed not to depend on collagen cross-linking and, thus, did not show a 
correlation with load at 5% stretch. Collagen TPF did show increased intensity with 
mTG treatment and mechanical properties, though its correlation coefficient with load at 
5% stretch was weak (r = 0.666). Collagen TPF/SHG exhibited the highest correlation 
with load at 5% stretch with a correlation coefficient, r = 0.918.  
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Figure 3- 3. Load (g) at 5% stretch correlates well with TPF/SHG ratio compared with 
SHG mean or TPF mean. Plots of load (g) at 5% stretch as function of SHG mean (A), 
TPF mean (B) and TPF/SHG ratio (C). 
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Figure 3- 4. Representative SHG images of control and mTG-treated collagen ECM 
used to create collagen matrix mask which can be inverted to highlight matrix porosity 
(negative mask). Scale bar is 50 µm. 
 
Microstructural Properties of Collagen Matrices Remained Unchanged with mTG 
Treatment  
      Mechanical testing and NLOM experiments demonstrated that collagen nonlinear 
mechanical and optical properties were modulated with mTG treatment. We next 
characterized gel microstructural properties with SHG. Representative and processed 
SHG images were shown in Figure 3-4 of control and 100 and 500 μg/ml mTG treated 
collagen gels. Binary masks of collagen fibrous structures were obtained by applying 
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fuzzy thresholding algorithms non-discriminately to all images (see Methods). The 
negative of these masks were used to highlight gel porosity. These negative binary 
masks were used to further quantify the physical properties of porosity, pore size, and 
pore number per unit area (see Figure 3-5). Porosity is defined as the ratio of void to 
total area. Porosity was quantified for control and mTG treated collagen gels and shown 
in Figure 3-5A. The bar graph reveals no significant difference in porosity compared 
with control with values of 0.765±0.050, 0.760±0.034, and 0.764±0.032 for control, 100, 
and 500 µg/ml mTG treated gels, respectively. Pore sizes of control and 100 and 500 
μg/ml mTG treated collagen gels were quantified and were shown in boxplot in Figure 
3-5B. Median pore sizes measured 14 µm2 and there was no difference between each 
group. Pore number per field of view was quantified under the same field of view 
(80µmx80µm), see Figure 3-5C. For control and 100 and 500 µg/ml mTG treated 
collagen gels, pore numbers were 253.7±57.9, 258.8±50.7 and 254.6±47.5 respectively, 
with no significant difference from control.  
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Figure 3- 5. Porosity, pore size and pore number per field of view of collagen ECM 
don’t change with mTG treatment. Bar graph of porosity (void fraction) (A), boxplot of 
pore size (B) and bar graph of pore number per field of view (C) in control and mTG 
treated collagen ECM. 50 SHG images were analyzed. Error bars in (A) and (C) 
represent mean+/-STD. 
 
 
Matrix Stiffness Promoted Angiogenic Responses 
      With mTG treatment, collagen gels (3.5 mg/ml) bore higher loads without concurrent 
changes in microstructural properties. Thus, we measured angiogenic responses to 
changes in stiffness of control and mTG treated 3D collagen gels. Monolayer of human 
umbilical vein endothelial cells (ECs) was induced to undergo angiogenic 
morphogenesis, i.e., invade the underlying collagen gel and form lumens. After 48 
 91 
 
hours, cultures were fixed, stained with toluidine blue, and sectioned transversely for 
cross-sectional views. Representative photographs of sectioned cultures from control and 
500 µg/ml mTG treated collagen gels were shown in Figure 3-6A and illustrate that 
stiffer matrices promoted angiogenic responses including more invading structures and 
deeper invasion distances. The number of invading angiogenic structures was quantified 
using a 4x objective (~1 mm2) and shown in bar graph in Figure 3-6B. The highest 
number of invading structures was observed in collagen gels stiffened with 500 µg/ml 
mTG (76.7±3.2) which was significantly (statistically) greater than the number measured 
in control (59±8.9) and 100 µg/ml mTG treated collagen gels (68±6.1). Also, angiogenic 
sprouts invaded deeper in collagen gels stiffened with 500 µg/ml mTG (266.4±94.2 µm) 
than controls (173.2±66.5 μm) as shown in Figure 3-6C. However, collagen gel stiffness 
did not appear to affect diameters of the formed lumens. There was no significant 
difference between lumen diameters formed in control (20.4±12.1 µm) and 500 µg/ml 
mTG treated collagen gels (24.5±14.4 μm) as shown in Figure 3-6D.  
Lumenogenesis in Stiffer Matrices Resulted in More Collagen Matrix Remodeling 
      We have previously shown that NLOM is capable of observing and quantifying EC-
ECM interactions noninvasively without using stains or dyes [407]. In our previous 
study, we observed collagen remodeling as a result of lumenogenesis and higher 
perilumenal collagen density than of the surrounding collagen matrix. This perilumenal 
collagen density was quantified as collagen intensity ratio (CIR) and varied 
proportionally with lumen size. CIR was calculated by normalizing perilumenal collagen 
SHG intensity by that of the surrounding collagen matrix. Thus, CIR may be used as a 
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measure of local collagen density (as a multiplicative factor of the surrounding matrix 
density) assuming no changes in collagen fiber diameters. In this study, we measured 
CIR as a function of matrix stiffness and used recently integrated OCM [408] to validate 
local measures of collagen density.  
 
Figure 3- 6. Stiffer matrix promotes angiogenic invasion with more structures invading 
deeper into collagen gel. Cross-sectional images of control and 500 µg/ml mTG-treated 
cultures stained with toluidine blue at 48 hours (A). Scale bar is 250 µm. Quantification 
of invading structure number (B), invasion distance (C), and lumen diameter (D) in 
control and 500 µg/ml mTG-treated collagen gels at 48 hours. Symbol * represents 
p<0.05. 
 
      Angiogenic 3D cultures were imaged with NLOM-OCM after 72 hours. 
Representative SHG, TPF, and OCM images were shown in Figure 3-7 of lumen cross 
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section formed within control and 100 and 500 μg/ml mTG treated collagen gels. SHG 
was used to specifically image collagen and its spatial distribution around a lumen 
forming sprout. TPF was used to specifically image green fluorescent protein expressing 
ECs lining the formed lumen. In contrast, OCM was non-specific and derives contrast 
from both ECs and collagen matrix.  
 
 
Figure 3- 7. Representative images of simultaneously acquired collagen SHG, cellular 
TPF, and non-specific OCM from within control and mTG-treated 3D cultures. Cultures 
were fixed at 72 hours. Scale bar is 50 µm. 
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      When visualized with NLOM-OCM en face images, lumen areas may be measured 
in contrast to lumen diameters when using transverse sections of 3D cultures (as in 
Figure 3-6). Consistent with lumen diameters quantified with transverse sections, no 
significant difference in lumen area was measured in mTG treated collagen matrices 
(5414.5±500.9 and 5752.2±404.8 µm2 in 100 and 500 µg/ml mTG, respectively) 
compared with controls (5872.2±651.0 μm2) as shown in Figure 3-8A. However, the 
amount of collagen remodeling as quantified by CIR around lumens was higher in stiffer 
matrices. CIR around lumens formed in 500 µg/ml mTG treated collagen gels measured 
2.2±0.1 times higher density than surrounding matrix compared with 1.9±0.1 and 
1.8±0.1 for control and 100 µg/ml mTG treated gels, respectively (see Figure 3-8B). 
Furthermore, if we normalized each CIR measurement to lumen area, matrix remodeling 
(as measured by CIR/lumen area) during lumenogenesis increased in stiffer matrices 
(Figure 3-8C).  
      Finally, we validated SHG measures of CIR with OCM. A complicating factor when 
quantifying collagen density with SHG is that its intensity has a quadratic relationship 
with pathlength. In other words, SHG will vary quadratically with path length in 
nonlinear medium, in this case, the collagen fiber. OCM contrast, however, depends on 
backscattered light. Thus, using the same image regions we calculate CIR with 
simultaneously acquired SHG and OCM and plot their correlation in Figure 3-8D. A 
dotted line is shown for exact correspondence, i.e., CIR(SHG) = CIR(OCM). The 
correlative plot measured a correlation coefficient R = 0.8247.  
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Figure 3- 8. Greater matrix remodeling is observed during lumenogenesis in stiffer 
matrices. Bar graph of lumen area (A), luminal collagen intensity ratio (CIR) (B), and 
CIR normalized by lumen area in control and mTG-treated cultures (C). Correlative plot 
of OCM and SHG derived CIR showing correspondence between linear and nonlinear 
signals (D). Error bars represent mean +/- SE. Sampling number n=35, 25, 50 in (A-B) 
and n=304, 218, 503 in (C) for control, 100 µg/ml mTG and 500 µg/ml mTG 
respectively. Symbol * represents p<0.05. 
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Figure-3- 9. Scatter plot of TPF/SHG ratio from 45 images in acellular regular mTG and 
denatured mTG-treated collagen gels (A). Scatter plot of TPF/SHG ratio from 75 images 
in acellular regular mTG-treated collagen gels (B). Bar graph of mean SHG/TPF ratio in 
regular mTG-treated and denatured mTG-treated acellular collagen gels (C). In statistics 
table, region highlighted with black color represents for significant difference with 
p<0.05. Error bars stand for mean+/- STD. 
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Discussion 
 
      Here, we evaluated biochemical state of mTG-treated collagen with SHG and TPF 
signals from NLOM, validated the effectiveness of mTG in enhance collagen stiffness, 
correlated optical property with mechanical property and characterized the 
microstructure. mTG induced the change in optical properties since denatured mTG 
showed no effect in changing TPF/SHG ratio at all (Figure 3-9). Among topographical 
properties in microstructure, we also characterized spectroscopically whether mTG 
treatment resulted in changes in collagen fiber diameters (explain this procedure. It’s not 
trivial). The corresponding scatter graphs of quantification results of porosity, pore size, 
pore numbers per field of view were shown in ECM (Figure 3-10). The intrinsic 
properties of linearity and nonlinearity from OCM and SHG could be used to identify if 
matrix fiber thickness changed with mTG treatment. The representative SHG, OCM 
images of acellular matrices for each condition were shown in Figure 3-11A. In the 
result of fiber thickness quantification, the OCM/SHG ratios were 2.446±0.331, 
2.485±0.229 and 2.412±0.242 for control, 100 µg/ml mTG and 500 µg/ml mTG 
respectively (Figure 3-11C) with no significant difference between conditions. 
Therefore, cross-linking with mTG stiffened collagen matrices with evidence of optical 
and mechanical properties while remaining their topographical properties unchanged. 
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Figure-3- 10. Scatter plots of porosity (A), pore size (B) and pore number (C) in 
acellular collagen ECM in control and mTG-treated collagen gels. Sample number n=50. 
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Figure-3- 11. Representative SHG and OCM images of acellular control and mTG-
treated collagen gels (A). Scatter plot of OCM/SHG ratio from 75 images in acellular 
control and mTG-treated collagen gels (B). Bar graph of mean OCM/SHG ratio in 
acellular control and mTG-treated collagen gels (C). Error bars stands for mean +/- STD. 
 
      There are various groups report optical properties of type I collagen [166, 229, 233] 
or crosslinked type I collagen [165, 230-232] with NLOM. The fluorescence emission 
spectrum and fluorescence maxima of collagen [229] or collagen treated with crosslinker 
[231] is excitation wavelength dependent and is crosslinker/crosslinker concentration 
dependent [231, 232] for cosslinked collagen.  Our result showed similar trend that TPF 
(but not SHG) increase with mTG dose and same trend is also shown in TPF/SHG ratio 
(Figure 3-2B). For collagen or crosslinker-treated collagen, the fluorescence intensity of 
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collagen increases with incubation time [229, 231, 232]. After collagen polymerization, 
Pyridinium-type crosslink (pyridinoline) will produce fluorescence have been proven 
experimentally [411-413] but whether mTG induced fluorescence in the same manner 
still needs to be addressed. SHG of collagen, the reflectance of the microstructure 
morphology, will not change with incubation time [229] but SHG of crosslinked 
collagen might change with time, which depends on crosslinker. For example, SHG of 
glycated crosslinked collagen [232] increased with incubation time but not SHG of 
genipin crosslinked collagen [231]. In our result, SHG showed little variance with time 
from Day 1, Day 2 to Day 7 but TPF signal increased with incubation time (data not 
shown) as evidenced with Figure 3-2A and that corresponds to another result that 
TPF/SHG ratio increased with incubation time Figure 3-2B. 
      Raub et al. [165] showed that TPF signal of collagen increased with glutaraldehyde 
treatment but not SHG signal and glutaraldehyde also enhanced collagen storage 
modulus from rheology measurement. Compared with glutaraldehyde, mTG crosslinked 
collagen enzymatically, not chemically and nontoxic at all. Here, mTG also enhanced 
collagen stiffness and increased TPF signal and TPF/SHG ratio but not SHG dependent 
on dose and incubation time (Figure 3-1 and 3-2). Compared with other group correlates 
mechanical property with TPF alone [165], our result showed TPF/SHG (r=0.91, Figure 
3-3C) linearly correlates with acellular scaffold stiffness better than SHG (r=0.36, Figure 
3-3A) or TPF (r=0.66, Figure 3-3B).   
      Collagen microstructures could be modulated with pH, temperature and 
concentration during collagen entropy-driven self-assembly fibrillogenesis processes 
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[159, 172, 203] and have been characterized using confocal [201, 202] or nonlinear 
optical microscopy [165, 166, 230, 233]. Increasing pH decreases fiber diameter and 
pore size but increases pore density and finally results in increasing storage modulus 
[166]. Increasing temperature decreases fiber diameter and pore size and results in 
increasing storage modulus [165]. With confocal microscopy, Yang et al. [201, 202] 
showed that increasing collagen concentration decreases fiber diameter, fiber length and 
pore size but increases fiber number and finally results in increasing storage modulus. 
Here, we investigated mTG influence on collagen microstructure and we noticed that 
there is no change with porosity, pore size and pore number per field of view (Figure 3-5 
and Figure 3-10). The pore size average value in our study using MATLAB algorithm 
was around 14 µm2 for 3.5 mg/ml, which was comparable with Yang’s study (mesh size 
around 4 µm for 3.5 mg/ml) [201] or Raub’s study (10 µm2 for 4 mg/ml) [166] and they 
both used particle feature of image J for the pore size quantification. Instead of directly 
measuring fiber diameter from SHG images, we took advantage of properties difference 
(nonlinear vs. linear) of SHG and OCM and used OCM/SHG ratio to evaluate influence 
of mTG on fiber thickness variation. Our result showed that OCM/SHG ratio doesn’t 
change with mTG dose with value =2.4 but that ratio will change with collagen 
concentration (data not shown) which agrees with other studies [201, 202, 233].  
        Researchers tried to address how ECM stiffness or compliance influences 
angiogenesis and most of them modulated ECM stiffness via changing ECM protein 
concentration, such as collagen [162, 271] or fibrin [136-138, 273], and concluded 
angiogenesis prefers compliant ECM. However, varying densities would change ligand 
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densities, mechanical properties and topographical properties at the same time [201, 202, 
233].  Study done by Critser et al. [162] revealed that via controlling matrix 
concentration, there were more cord like network formation in stiffer gel (3.5 mg/ml) 
compared with compliant gel (0.5 mg/ml) but after in vivo subcutaneous implantation, 
significant increased vessel sizes occurred in stiffer matrix (3.5 mg/ml) after 14 days of 
transplantation. Yamamura et al. [133] modulated pH to vary collagen gel stiffness and 
concluded that thicker and deeper capillary networks were formed in rigid gel other than 
compliant gel. Even though changing pH will also change collagen microstructure [166] 
but the extent of microstructure changing was less than varying collagen concentration 
[166, 174] with remaining ligand densities. mTG enhanced ECM stiffness (Figure 3-1) 
without changing topographical properties (Figure 3-4 & 3-5 and Figure 3-10 & 3-11) 
and our 3D angiogenesis assay showed that in 3.5 mg/ml collagen gel, more capillary 
structures formation in stiffer ECM with deeper invasion distance but no difference in 
lumen diameter (Figure 3-6). Even though mTG crosslinked collagen gel has been 
extensively washed with M199, the possibility of residue mTG influencing EC invasion 
behavior cannot be ruled out. We setup another control experiment via adding mTG into 
media after HUVEC monolayer formation, therefore the underneath collagen stiffness 
would be the same and the result revealed less invasion structures and shorter invasion 
distance in topical mTG well compared with control (Figure 3-12 & Figure 3-13). The 
retardation of EC invasion in topical mTG well might owe to mTG’s ability to crosslink 
cell junctions [414]. 
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Figure-3- 12. Cross-sectional images of sectioned cultures stained with toluidine blue in 
control and cultures with topically applied mTG in media above monolayer at 72 hour 
(A). Scale bar is 250 µm. Invading structure number (B), invasion distance (C) and 
lumen diameter (D) in control and cultures with topically applied mTG in media above 
monolayer. Sample number n=4 gels in (A) and n=127, 111 in (C) and n=57, 44 in (D) 
for control and 500 µg/ml mTG-treated gels respectively. Symbol * represents p<0.05. 
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Figure-3- 13. Number of invading angiogenic invading structure number is enhanced in 
mTG-treated collagen ECM but is suppressed in 3D cultures with topically applied mTG 
in media above monolayer. Invading structure number at 48 hours (A) and 72 hours (B) 
in control, mTG-treated collagen and topically applied 3D cultures. In statistics table, 
region highlighted with black color represents for significant difference with p<0.05. 
 
      Lumen expansion during angiogenesis required synergistic of cell traction and 
membrane-associated metalloproteinase and cell-matrices interaction during 
lumenogenesis could be observed with NLOM as evidence of collagen intensity ratio 
(CIR) increasing with lumen expansion [407]. With NLOM, we observed that CIR 
increased with increasing stiffness (Figure 3-7 & 3-8) with CIR=1.88±0.06 for control 
and 2.23±0.06 for 500 µg/ml but average lumen size didn’t change (5872.2±650.9 µm2 
for control and 5752.1±404.8 µm2 for 500 µg/ml). To rule out lumen size effect, the 
normalized CIR still showed the same trend, i.e. higher normalized CIR in stiffer 
matrices than control. With NLOM-OCM combined system, we further concluded that 
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higher collagen density around the lumen in stiff matrices (Figure 3-8D).  The amount of 
cell traction and the size of focal adhesion depend on resistance (stiffness) of ECM [275] 
and cell traction is necessary for focal adhesion growth and maintenance [297-302, 415] 
and cell-cell adherens junctions mediation [298, 320]. Cell-ECM traction modulates the 
tension in cell-cell contact [322] and the size of cell-cell junctions [321]. Cell mobility 
could be regulated by the crosstalk between cell-cell junction and integrin adhesions 
[416]. The higher CIR value in stiffer matrices implies higher traction generated by ECs 
and that higher traction might be necessary to maintain vessel integrity and control 
vessel permeability [105].  
      In conclusion, we were the first to report optical properties of mTG treated collagen, 
correlated optical properties with mechanical properties measuring with biaxial 
bioreactor and successfully decoupled matrix stiffness with concentration for 
angiogenesis response investigation. Our result revealed matrix stiffness promotes 
angiogenesis in 3.5 mg/ml collagen concentration.  
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CHAPTER IV 
CONCLUSION AND FUTURE WORK 
 
Conclusion 
 
      The interactions between endothelial cells (ECs) and the extracellular matrix (ECM) 
are fundamental in mediating various steps of angiogenesis. Here, EC-ECM interactions 
have been characterized using a noninvasive and non-destructive nonlinear optical 
microscopy (NLOM) technique to optically image endothelial sprouting morphogenesis 
in 3D collagen matrices using second harmonic generation (SHG) and two-photon 
excited fluorescence (TPF), respectively. Lumenogenesis associated with increasing 
collagen density around its periphery is the synergistic result of membrane-associated 
matrix metalloproteinase activity and the generation of cell tension, as evidenced with 
proteinase inhibition and Rho-associated kinase (p160ROCK) inhibition studies. 
Collagen microstructure plays a pivotal role in regulating angiogenesis and also 
determines its mechanical stiffness. With a combined NLOM-OCM system, probing 
microstructure, optical and mechanical properties noninvasively is feasible. A linear 
relationship between optical properties (TPF/SHG) and mechanical properties could 
enable us to probe local mechanical properties of tissues noninvasively; However, this 
area of study will need further investigation, such as incorporating other topographical 
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properties to predict ECM stiffness. We successfully decoupled ECM stiffness from 
ligand concentration by applying mTG to strengthen collagen scaffold stiffness and were 
able to demonstrate that increasing ECM stiffness enhanced angiogenic responses in 
vitro. The result of mTG modulated collagen stiffness while maintaining its 
topographical properties might aid the tissue engineering and regenerative medicine 
fields. For example, generating a collagen scaffold with gradient stiffness using mTG 
would allow testing whether durataxis regulates the speed of wound healing and cell 
migration in three-dimensional matrices. The results from the mTG topical control 
experiment were also encouraging; mTG successfully retarded EC migration, which may 
be important for cancer research. Further investigation into presentation of altered matrix 
stiffness and how it affects EC migration in three dimensions is needed. 
 
Future Work 
 
      Together the work presented here studies endothelial cell interactions with the 
extracellular matrix in angiogenesis. The data show the effectiveness of mTG in 
enhancing collagen scaffold stiffness and the powerful ability of NLOM-OCM 
combined system in probing optical, mechanical and topographical properties 
noninvasively. With these abilities, we could further investigate cell-matrix interactions 
in a wound healing model, the influence of collagen microstructure on angiogenesis, and 
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the effects of altering the stiffness gradient on angiogenic patterning. Future works 
include: 
1. Cell/Matrix Interactions during Angiogenesis in Fibrin and Fibrin/Collagen Mixture 
2. Influence of Collagen Microstructure on Angiogenesis 
3. Influence of Stiffness Gradient on Angiogenesis 
 
Cell/Matrix Interactions during Angiogenesis in Fibrin and Fibrin/Collagen 
Mixture 
Motivation 
      Wound healing, an integration of dynamic interactive processes, consists of four 
overlapping stages: hemostasis, inflammation, proliferation (re-epithelialization and 
granulation tissue formation), and tissue remodeling [417, 418]. Wound healing is an 
integration of dynamic interactive processes involving soluble mediators [417, 419], 
formed blood elements, ECM [420], and parenchymal cells [421]. Successful hemostasis 
is dependent on fibrin clot formation, platelet adhesion, and aggregation [421]. 
Granulation tissue forms via combination of fibroplasia and neovascularization and 
consists of neovessels, macrophages, fibroblasts, and loose connective tissue. Once the 
wound is filled with granulation tissue and covered with neoepidermis, fibroblasts 
transform into myofibroblasts, which contract the wound [420]. ECM remodeling, cell 
maturation, and cell apoptosis create the third phase of wound repair, which overlaps 
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with tissue formation. The dynamic reciprocity of complex interaction and feedback 
control of cells-cytokines-enzyme-matrix control the dynamics of provisional matrix in 
wound healing and transition from an initial fibrin-fibronectin-rich ECM, to an 
intermediate fibrin-collagen mixture, and in the end a collagen rich scar tissue [420]. 
Angiogenic capillaries begin to invade fibrin rich clots, organize into capillary networks, 
and diminish gradually with collagen accumulation as the granulation tissues produce 
collagen-rich scar tissue [422]. The spatial and temporal dynamic cell-matrix 
interactions of angiogenesis in heterogeneous ECM proteins are still unclear, which 
makes the possibility of studying heterologous matrices compelling. 
Preliminary result or method 
      In Figure 4-1 showed the preliminary result of using NLOM-OCM combined system 
in imaging 3D acellular fibrin/collagen mixture while protein concentration (4 mg/ml) 
was kept constant. Figure 4-1 also highlights the capability of OCM in capturing fibrin 
microstructure non-invasively. Fibrin microstructure is clearly modulated by thrombin 
concentration (0.01 U/mg created more fibrous fibrin microstructure, especially at 
fibrin/collagen ratio of 90:10 and 80:20). Therefore, noninvasively characterizing cell-
matrix interactions spatially and temporally during angiogenesis in fibrin or 
fibrin/collagen mixture is feasible with our NLOM-OCM combined system. Similar to 
collagen, fibrin microstructure are also influenced by various factors [423-425], such as 
fibrinogen concentration, thrombin concentration, calcium concentration and ionic 
strength.   
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Figure 4- 1. Using NLOM-OCM combined system to image acellular fibrin and 
fibrin/collagen mixture 3D matrices modulated by thrombin concentration. Scale bar=50 
µm 
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Influence of Collagen Microstructure on Angiogenesis 
Motivation 
      Whether ECM stiffness or microstructure or both of them plays a pivotal in 
angiogenesis has been debated for a while. Our results revealed that collagen stiffness 
tuned by mTG enhanced more cell-matrix interaction, induced deeper capillary structure 
invasion but had no influence on lumen size (see Chapter III). So will ECM 
microstructure influence lumen size during angiogenesis? In order to address that 
question, we have to modulate ECM microstructure while keeping stiffness constant.    
 
Preliminary result or method 
      In chapter I, our review of previous works revealed collagen microstructure could be 
tuned with concentration, pH, temperature and ionic strength during fibrillogenesis. In 
chapter III, we showed that mTG could modulate collagen ECM stiffness with mTG 
dose and incubation time. Therefore, study of microstructure influence on angiogenesis 
could be performed with using gels with same stiffness but different collagen density. In 
preliminary study (Figure 4-2), we modulated collagen microstructure via collagen 
concentration (1, 2.5 and 3.5 mg/ml), and treated with mTG of different dose and 
incubation time, and evaluated mechanical properties. We noticed that we could get the 
same mechanical response in two groups (listed in Table 4-1). Therefore, it’s feasible to 
study microstructure influence on angiogenesis. Also, intense TPF images correspond to 
the groups with longer incubation time (Figure 4-2B). mTG can crosslink fibrin [426], 
gelatin [427, 428], collagen [188, 429-432] and matrigel [433] but no report about 
heterogeneous ECM protein crosslinking with mTG. If we could crosslink fibrin in our 
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3D model and even crosslink collagen/fibrin mixture, we could push this study further 
into how heterogeneous microstructure influence on angiogenesis. 
 
Table 4- 1. Groups with same mechanical testing result from gels with different 
concentration, mTG dose treatment and incubation. 
 
group concentration mTG dose Incubation time 
1 1 mg/ml 500 µg/ml 7 days 3.5 mg/ml 0 µg/ml 2 days 
2 2.5 mg/ml 500 µg/ml 7 days 3.5 mg/ml 400 µg/ml 2 days 
 
Influence of Stiffness Gradient on Angiogenesis 
Motivation 
      During tissue development, inflammation and wound healing, cells experience 
gradients of physical and chemical cues, which influence their migration, proliferation 
and differentiation [434]. ECM with gradient properties can connect mechanically 
mismatched tissues [435, 436]. Interface tissue engineering (ITE), the new emerging 
field in regenerative medicine, aims to generate functional biological tissue to repair or 
replace the diseased or damaged tissue at interfaces of different tissue types. It is 
potentially important for controlled angiogenesis for implantation of tissue-engineered 
devices and will provide new ideas to vascular remodeling and angiogenesis [437-440]. 
Human body’s interface tissues consist of complex structures and gradient physical 
properties which cannot be regenerated using conventional isotropic or monophasic 
scaffolds [440]. Gradient biomaterials are materials with anisotropy in composition, 
structure, mechanics and biomolecular level. Gradients in biology include chemical and 
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physical gradients. Chemical gradients [441] include gradients of morphogens, such as 
transcription factors [442, 443], chemokines [444], and cytokines [445-448]. Physical 
gradients include gradual changes in physical properties, such as stiffness [113, 449, 
450], porosity, pore size [450-452] and other topographical properties. The challenge in 
ITE is to vascularize interface tissue and improve the efficiency of 3D cell culture. 
Gradient materials influence cell behaviors, such as cell migration [453], osteoblast 
differentiation [442] etc., but how gradients influence angiogenesis and cell-matrix 
interactions still need further investigation. 
 
Figure 4- 2. Mechanical characterizing results by biaxial bioreactor in collagen with 
different concentration, different mTG dose treatment and different incubation time. (A) 
mechanical characterization results. (B) microstructural characterization with NLOM-
OCM combined system. COL: collagen, mTG: microbial transglutaminase, scale bar 
=50 µm 
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Preliminary result or method 
      Collagen has been applied in ITE in creating multiphase [454] and gradient tissues 
[455]. We showed our capability to noninvasively investigate cell-matrix interactions 
during angiogenesis (chapter II), enhance collagen matrix stiffness with mTG while 
keeping microstructural properties constant and probe stiffness of collagen scaffold 
noninvasively (chapter III). Therefore, it’s feasible for us to create either two-phase or 
gradient scaffolds to study stiffness influence on angiogenesis without transition region 
(two-phase) or with transition region while keeping microstructural properties and ligand 
density unchanged. To create biphasic collagen scaffold, we could adapt the method 
from Gillette et al. [454] to polymerize one layer over the other at different times. To 
create gradient stiffness matrices, we could adapt the method of diffusion [434, 437, 
456-458] which employed molecular diffusion between two chemical sources in two 
sinks at 37 ºC. Another possible method was proposed by Nam et al. [455] which create 
3D collagen with stiffness gradient through dialysis at 4 ºC for 48 hours. 
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